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Novel Roles for B-Raf in Mitosis and Cancer
Meghan E. K. Borysova
ABSTRACT

The MAP kinase pathway is well known for its key roles in regulating cell
proliferation and cell cycle progression. MAP kinases have also been implicated in
mitotic functions, however these functions are less-well understood. Recent studies from
our laboratory used Xenopus egg extracts to identify B-Raf as an essential activator of the
MAPK cascade during mitosis. Therefore, the first objective of my dissertation research
was to determine if B-Raf has functional significance during mitosis in human somatic
cells.
Using RNA interference against B-Raf and various immunofluorescence
techniques, I show that B-Raf: (1) localizes to and is phosphorylated at a key mitotic
structure, (2) is critical for proper mitotic spindle assembly and chromatin congression,
(3) is important for the engagement of microtubules with kinetochores during mitosis,
and (4) is necessary for activation of the spindle assembly checkpoint.
It has been demonstrated that B-Raf is a prominent oncogene, constitutively
activated in the vast majority of melanomas and other cancers. I hypothesized that
oncogenic B-Raf expression perturbs mitosis and causes aneuploidy.
First, we show that oncogenic B-Raf expression correlates with mitotic
abnormalities in human melanoma cells and that spindle defects are induced when
xi

oncogenic B-Raf is ectopically expressed. Further, using FISH and karyotype analysis, I
demonstrate that oncogenic B-Raf drives aneuploidy and chromosome instability in
primary, immortalized, and tumor cells.
In summary, my dissertation studies elucidate novel roles for B-Raf in
mammalian mitosis. In addition, my studies show for the first time that oncogenic B-Raf
disrupts mitosis causing chromosomal instability. I propose that oncogenic B-Rafinduced chromosome instability contributes to tumorigenesis.

xii

CHAPTER 1
BACKGROUND AND INTRODUCTION

Mitosis
The cell cycle is the order of processes by which a cell duplicates and divides its
DNA equally into two identical daughter cells. The cell cycle consists of temporally
coordinated interphase (G1, S, G2 phases) and mitosis (prophase, metaphase, anaphase
and telophase). During interphase cells prepare for mitosis through cell growth, DNA
duplication and nutrient accumulation. Mitosis is the ultimate stage in the cell cycle
during which the cell partitions its chromosomes and subsequently divides its
cytoplasmic components into two identical and distinct daughter cells.

Stages of Mitosis
Mitosis is an irreversible process whose stages have traditionally been described
by gross structural and behavior changes documented by light microscopists. Modern
use of fluorescence microscopy has aided in the identification of mitotic stages (Fig. 1).
Proteins and enzymatic activities which regulate these morphological changes and their
transitions serve as biochemical markers for some of the mitotic phases.
Entry into mitosis directly follows the latter part of the second gap (G2) phase
during which cells can be reversibly arrested in response to various stresses [1]. Passage
through late G2 serves as a ‘point of no return’ and marks the termination of interphase
1

Interphase

Prophase

Metaphase

Anaphase

Telophase

Figure. 1 Stages of mitosis
a. Interphase cells have polymerized microtubules, and the decondensed chromatin resides within the nucleus surrounded
by a nuclear membrane. b. Prophase is the first stage of mitosis; microtubules are depolymerized from their interphase
stage, the DNA begins to condense, the nuclear envelope is broken down and the two centrosomes migrate to opposite
poles. c. During metaphase, condensed chromosomes align at the metaphase plate and the bipolar spindle is formed. d.
In anaphase, the spindle pulls the chromosomes in a poleward directions. e. During telophase/cytokinesis, the DNA is
partitioned into two distinct regions, the nuclear envelopes reform and the cell pinches off into two daughter cells.
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and the beginning of mitosis. The phases of mitosis are most frequently referred to as
prophase, prometaphase and metaphase – the stages of early mitosis; and anaphase and
telophase - the phases of mitotic exit.
Prophase is the initiating stage of mitosis. It is traditionally defined as the point at
which condensing chromosomes are first visible in the membrane-bound nucleus when
observed by light or fluorescence microscopy. As well during prophase, the two
centrosomes (the mother centrosome is duplicated during S-phase) move to opposite
poles of the cell [2] where they initiate microtubule nucleation into focal arrays called
asters[3]. Centrosomes and asters are visible via fluorescence microscopy. Prophase is
accompanied by the nuclear accumulation and activation of cyclin B-Cdk1 (also termed
M-phase promoting factor, MPF), the master regulator of mitosis [4-9]. Cyclin B-Cdk1
remains active throughout prophase, prometaphase and metaphase and, therefore, serves
as a biochemical marker of early mitosis. It has been shown that Cyclin B-Cdk1
regulates chromosome condensation through direct phosphorylation of the condensin
complexes [10-12]. Estimates reveal that DNA is compacted 1000-2000 fold over
interphase chromosomes [13] and chromosome condensation is generally completed
during prophase. The significance of prophase events cannot be understated.
Chromosomes condensation reveals the centromeres upon which the attachment sites for
spindle microtubules are assembled. Centrosome segregation is crucial for the
organization of a bipolar spindle. Aster formation serves to properly position the mitotic
spindle. Prophase ends and prometaphase is initiated when nuclear envelope breakdown
become visible by light microscopy. Nuclear envelope breakdown is largely a
consequence of phosphorylation of nuclear lamins by the Cyclin B-Cdk1 complex [14].
3

The nuclear membrane fragments into small vesicles which are eventually fuse during
telophase to form the new intact nuclei. Breakdown of the nuclear envelope permits the
chromosomes to physically associate with the polymerizing microtubules. Each
chromosome has two sister kinetochores, one on each of the fused sister chromatids.
During prometaphase kinetochores attach to the microtubules emanating from both poles
of the developing spindle [15]. A spindle checkpoint arrest prevents anaphase onset until
all kinetochores are fully engaged [16]. Following full engagement, kinetochore
associated motor proteins direct the movement of attached chromosomes toward the
spindle poles. Spindle microtubule growth acts as an opposing force that pulls the
chromosomes toward the center of the mitotic spindle [17]. Eventually the forces balance
thus aligning the chromosomes at the spindle equator, called the metaphase plate. It is at
this point of chromosome congression that the cell has entered metaphase.
During metaphase chromosomes are aligned at the equator of an organized, fully
formed, bipolar spindle (Fig. 2). Cyclin B-Cdk1 remains active during metaphase. Sister
chromatids remain fused by cohesin complexes at the region of the centromere [18-20].
Metaphase ends and anaphase is initiated when sister chromatids are disjoined.
Sister chromatid segregation results from the abrupt and synchronous degradation of the
cohesin molecules that hold them together [21-23]. The onset of anaphase occurs when
the anaphase promoting complex/cyclosome (APC/C) becomes active. APC/C is an E3
ubiquitin ligase which targets a number of mitotic substrates including securin and Cyclin
B, for proteasome mediated destruction [24]. The destruction of securin allows for the
activation of separase which subsequently cleaves the cohesin molecules [25]. After the
dissolution of cohesin, kinetochore microtubules begin to shorten and kinetochore forces
4

Figure. 2 The mitotic spindle
The bipolar spindle apparatus formed during mitosis has several
key features: a. microtubules polymerize from the centrosomes
to the kinetochores; b. the kinetochores are a proteinaceous
structure to which the microtubules attach; c. the centrosomes
are the microtubule organizing center (MTOC) of mammalian
cells.
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result in poleward movement of the chromatids. This movement is detectable by light
microscopy and is termed early anaphase or ‘anaphase A’ which culminates when the
chromatids reach the poles. Late anaphase or ‘anaphase B’ then ensues during which
time poleward microtubules elongate thus the entire spindle elongates, thereby
partitioning the chromatids further apart [15]. Rapid degradation of cyclin B is the most
commonly used biochemical marker for anaphase and leads to the hallmarks of telophase.
Telophase is the final stage of mitosis during which the chromosomes and
cytoplasm are ultimately divided [15]. It is during this stage that the nuclear envelopes
reform around both sets of chromosomes, the chromosomes decondense, the
microtubules return to an interphase state and the cell is divided into two daughter cells.
All of these features are detectable through light and fluorescence microscopy. It is due
to the destruction of cyclin B-Cdk1 that components of the nuclear envelope and
chromosomes no longer undergo phosphorylation, thereby permitting the reformation of
the envelope and decondensation of chromosomes. Simultaneously, an actin-myosin
contractile ring positioned beneath the plasma membrane causes the membrane to
invaginate at the former site of the metaphase plate creating a cleavage furrow in the
cytoplasm. Following nuclear envelope reformation, the contractile ring pinches the cell
in half at the furrow, thus allowing for the equal separation of the cytoplasm, a process
termed cytokinesis. The completion of cytokinesis gives rise to two daughter cells both
of which are in the beginning stage of interphase.

6

Organization of the Mitotic Spindle
The mitotic spindle is the structural and functional unit of the cell that is
responsible for the mitotic partitioning the duplicated chromosome pairs. While the
structure of the spindle apparatus changes continually throughout mitosis, the
quintessential metaphase spindle is fusiform - elliptical in shape, having tapered spindle
poles and a wide midzone. The basic elements of the mitotic spindle are the centrosomes
and the microtubules (Fig. 2). While not primary components of the spindle,
chromosomes and kinetochores are necessary for the structural formation of the spindle
apparatus.
The spindle poles serve as the microtubule organizing centers (MTOC) that
initiate the formation of the mitotic spindle. In animal cells, the MTOCs are
centrosomes, organelles containing a pair of orthogonally arranged centrioles surrounded
by protein rich pericentriolar material, including pericentrin, ninein, γ-tubulin and others
[26-29]. The single centrosome of the cell is duplicated during S-phase. Early in mitosis,
Nek2 kinase promotes the migration of the two centrosomes to opposite poles of the cell
[30-33]. γ-tubulin and other members of the gamma complex protein family form
hundreds of ring-shaped γ-tubulin ring complexes per centrosome (γ-TuRC). γ-tubulin is
required for microtubule nucleation [34, 35] and, while the exact mechanism is not
completely understood, γ-TuRCs are most likely the sites of microtubule nucleation [3638].
Microtubule polymers are composed of α- and β-tubulin dimers whose orientation
in the polymerized microtubule gives microtubules their polarity. The opposing ends of
microtubules have different tubulin-polymerizing properties and orientations in the
7

mitotic spindle. The relatively static minus ends of the microtubules interact with the
pericentriolar material of the centrosome and the highly dynamic plus ends extend away
from the centrosome [39, 40]. These intrinsic features of polarity and dynamic instability
are what give the microtubules the ability to form the mitotic spindle.
At least three types of microtubules comprise the mitotic spindle, all of which
emanate from the MTOC. Astral microtubules are organized in radial arrays around both
centrosomes. They connect the spindle poles to the cortex of a mitotic cell, thus, are
critical for proper positioning of the mitotic spindle and mark the site for subsequent cell
division [41]. Interpolar microtubules polymerize toward the poles opposite of their
nucleation. They terminate in the body of the spindle where some of them interact with
the plus ends of antiparallel interpolar microtubules thus giving the spindle stability [42].
During late anaphase, the interpolar microtubules polymerize and slide thereby
elongating the spindle. Finally, the plus ends of kinetochore fibers (K-fiber), comprised
of 20-30 microtubules [43, 44], associate with, and are captured by, the outer
kinetochores of the chromosomes, thus connecting the chromosomes to the mitotic
spindle [41, 45]. During early anaphase, the kinetochore microtubules shorten forcing
the attached chromosomes to move in the direction of the spindle poles.
The centromeres of the chromosomes are specific regions of repetitive DNA
sequences, which are critical for proper organization of the mitotic spindle. First, they
are the site of fusion between the chromatids thus creating a visible constriction site in
metaphase chromosomes. Secondly, they are also the sites where two identical
proteinaceous structures called the kinetochores assemble and function. Kinetochores
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serve as the sites of microtubule engagement as well as the location of the spindle
assembly checkpoint.
Accurate positioning and function of the centrosomes, microtubules and
chromosomes are necessary for the proper formation of the metaphase spindle. A
properly formed spindle is fusiform in structure with sister chromatids bioriented and
symmetrically arranged at the spindle equator. Achieving this arrangement prior to
anaphase is critical in order to ensure equal segregation of chromosomes, thereby
maintaining the genomic integrity of both daughter cells.

Spindle Assembly Checkpoint
In order to prevent chromosomal missegregation from occurring, anaphase must
not proceed until all kinetochores are engaged in an amphitelic (bipolar) fashion. A
cellular surveillance mechanism called the spindle assembly checkpoint (SAC) ensures
that anaphase onset is delayed until all chromosomes have achieved bipolar attachments.
[16, 46, 47].
The process by which kinetochores capture K-fibers is largely a stochastic event
based on their own chance interactions. In brief, one sister kinetochore becomes engaged
with K-fibers of the spindle, generating a monotelic chromosomal attachment.
Subsequently the second sister kinetochore captures microtubules from the opposite pole
and the chromosome becomes bioriented. This somewhat random process can result in
syntelic attachments where K-fibers from one pole engage with both sister kinetochores.
As well, merotelic attachments can take place in which case K-fibers from opposite poles
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engage with one sister kinetochore. Therefore, monotelic attachments occur as a
transitional state prior to achievement of bipolar engagement [48].
Syntelic kinetochore-microtubule attachments cause chromosomes to be
positioned near one pole and such attachments elicits the SAC [49]. Merotelic
attachments are bipolar by definition, cause chromosomes to align at the metaphase plate
and do not elicit a SAC. The mechanism by which the syntelic chromosome orientation
is reversed is not understood. However, it has been proposed that Aurora B kinase is
instrumental in reversing maloriented attachments [50-54] by phosphorylating targets that
cause rapid microtubule turn-over at the kinetochores [55], after which amphitelic
attachments are free to take place.
On the biochemical level the metaphase-anaphase transition is driven by the E3
ubiquitin ligase activity of the APC/C which targets securin and cyclin B for proteasomal
degradation. The SAC functions as a sensory mechanism by detecting unattached
kinetochores and as an effector by inhibiting the activation of the anaphase promoting
complex/cyclosome (APC/C) (Fig. 3). The nature of the ‘wait anaphase’ signal is not
completely understood. However, it is widely accepted that the SAC protein complexes
assembled at unattached kinetochores early in mitosis and negatively regulate activation
of the APC/C, thus preventing anaphase onset [56-60].
A large complex of proteins including Mad1, Mad2, BubR1, Bub1, Bub3, Mps1
and Aurora B, comprise the core spindle checkpoint proteins in yeast [61-64] and
mammalian cells [65-67]. It is evident that the proteins of SAC require kinetochore
localization and function as large multi-componential protein complexes.
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Aurora B [68-70] and Mps1 [71-73] are required for recruitment and localization
of all other checkpoint proteins to the kinetochores. The current model for SAC activity
suggests that kinetochore bound Mad1 and Mad2 form a complex which can then bind
Cdc20, the activator of APC/C [74-78] and the key target of the SAC [79]. However,
Cdc20 binding by the Mad1-Mad2 complex is insufficient for inactivating APC/C.
BubR1/Mad3 and Bub3 are all required for full inhibition of the APC/C [80, 81]. The
BubR1 complex appears to synergize [59] with the Mad1-Mad2-Cdc20 complex by
forming a supercomplex that can fully inhibit the APC/C.
Several other proteins have been shown to be involved in the SAC, including the
ROD-SWILCH complex [82], p31 [83-85], cyclin B-Cdk1 [86, 87], NEK2 [88] and pololike kinase-1 (PLK1) [89]. The contribution of these proteins to the SAC is not well
understood.
The activity of the spindle assembly checkpoint is essential for preventing
chromosome missegregation and aneuploidy [90, 91]. The presence of a single
unattached kinetochore is sufficient to activate the SAC and the SAC is not turned off
until every kinetochore has formed fully saturated (25-30 microtubules) bipolar
microtubule attachments.
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Fig. 3 The spindle assembly checkpoint
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MAPK Pathway
The mitogen activated protein kinase (MAPK) pathway is highly conserved from
yeast to humans [92, 93]. MAPK signaling integrates a variety of extracellular and
intracellular signals to control a broad spectrum of cellular processes including
proliferation, survival, stress response and apoptosis [93]. A number of cooperating
molecular mechanisms regulate the cascade in order to ensure signaling specificity.

MAPK Cascade
The basic structure of the MAPK cascade is a module consisting of three kinases
which sequentially activate one another through phosphorylation events. The most
upstream kinases in the cascade are the serine/threonine kinases, MAP kinase kinase
kinases or MAPKKK (MAP3K). Upon their own activation, MAP3Ks phosphorylate
and activate the second kinase in the module, MAP kinase kinase or MAPKK (MAP2K)
[93, 94]. MAP2Ks are defined as dual-specificity kinases, for upon their activation, they
in turn phosphorylate a Thr-X-Tyr motif in the third cascade member, MAP kinase or
MAPK [93, 95]. Substrates of MAPK include transcription factors, phospholipases and
cytoskeleton-associated proteins.
The family of MAP3Ks, MAP2Ks and MAPKs is large, with at least 20 different
members of the mammalian MAPK family identified to date [96]. The four most well
described MAPK cascades are named for their relative MAPKs. Jun amino-terminal
kinases (JNKs) primarily serve in the response to cellular stress. p38 is also activated in
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response to cell stresses and plays a role in cytokine production in hematopoietic cells,
cytokine-stimulated proliferation and apoptosis. ERK5 is the least well known MAPK
cascade [93] and it has been suggested that ERK5 regulates cell survival and proliferation
[97, 98]. The most well studied MAPK pathway is extracellular signal-regulated kinases
1 and 2 (ERK 1/2).

Regulation and Functions of the ERK 1/2 Pathway
The ERK 1/2 cascade is implicated primarily in cellular proliferation,
differentiation, cell cycle regulation and cell survival [93]. ERK 1/2 phosphorylates
many known targets including transcription factors Elk1 [99], c-Fos [100] and p53 [101],
all of which play a role in cellular proliferation and transformation. As well, ERK targets
include the S6 kinase p90/RSK [102], phospholipase A2 [103], EGFR [93] and several
microtubule-associated proteins [103].
Activation of the ERK 1/2 cascade in response to mitogen stimulation has been
well studied. During cell cycle entry activation of the ERK1/2 cascade is triggered by
engagement and oligomerization of extracellular growth factor receptors [104] which in
turn, stimulates the conversion of Ras, a small GTP-ase, from its GDP-bound inactive
form to an active GTP-bound form [96, 105]. GTP-bound Ras mediates the translocation
of the MAP3K, Raf-1, to the membrane where it is activated by a yet undefined,
phosphorylation mechanism [106]. Raf-1 activates MEK which transmits the signal to
ERK1/2. Activated ERK1/2 phosphorylates cytoplasmic targets or translocates into the
nucleus where it phosphorylates transcription factors which promote S-phase progression
[96, 105].
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Mitotic Roles of ERK 1/2
It is well established that ERK 1/2 regulates the G1/S transition in response to
mitogen stimulation [96, 105]. A large but lesser known body of evidence suggests that
the ERK 1/2 pathway regulates various mitotic functions including entry and exit from
mitosis, spindle assembly, the spindle assembly checkpoint and Golgi apparatus
fragmentation (Fig. 4). Despite a growing body of evidence supporting mitotic roles for
ERK 1/2, a firm role for ERK 1/2 in mammalian mitosis has not been established.
Early evidence supporting a mitotic role for ERK 1/2 came from studies in
Xenopus egg extracts where it was shown that p42 (the Xenopus ERK 2 homologue) is
activated during M-phase [107-110]. As well, ERK activity during mitosis in NIH 3T3
and HeLa cells is detectable via western blot analysis using antibodies that recognize
activated ERK [111].
Importantly, reports using immunofluorescence microscopy support the early
conclusions from Xenopus egg extracts that ERK is activated during mitosis. Several
groups have demonstrated that in mammalian cells small pools of active ERK 1/2 and
MEK 1/2 are localized to the kinetochores and spindle poles throughout mitosis and to
midbody during cytokinesis [112-114] (Fig. 4). Activated p42 has also been shown to
localize to mitotic spindles in Xenopus egg extracts [115] as well as in fertilized sea
urchin eggs [116].
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Fig. 4 MAPK functions and localization during mitosis
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Functional studies have revealed roles for ERK 1/2 in mitotic entry in mammalian
cells but not in Xenopus egg extracts. In mammalian cells, expression of dominantnegative MEK [117], treatment with MEK inhibitors [111, 117] and RNA interference
(RNAi) of MEK 1/2 and ERK 1/2 [118] all induce a G2/M cell cycle arrest. As well,
such conditions decrease nuclear translocation of cyclin B-Cdk1 and delay and reduce its
activation [111, 117, 118]. Such data supports a role for ERK 1/2 in Cdk1 activation and
entry into mitosis in mammalian cells. However, cyclin B-Cdk1 is not affected by the
depletion of p42 from Xenopus egg extracts [110, 119]. To the contrary, constitutive
activation of p42 in this system inhibits cyclin B-Cdk1 and delays entry into mitosis [120,
121]. Further, evidence in Xenopus egg extracts revealed that p42 activates Wee1 kinase
which directly phosphorylates and inactivates cyclin B-Cdk1 [122]. However,
differences in the requirement of MAPK activity in mitotic entry between mammalian
cells and Xenopus egg extracts, may be explained by their inherently different cell cycles.
Indeed, while the cell cycle of somatic cells follows a classic G1-S-G2-M cycle, Xenopus
egg extracts recapitulate the embryonic cell cycle, which is comprised only of S and M
phases, with no gap phases in between. Therefore, Xenopus egg extracts may not possess
an active G2 phase molecular mechanism. Thus, a role for ERK 1/2 during mitotic entry
remains disputable.
ERK 1/2 has been implicated in assembly of the mitotic spindle in several model
systems. Early work in mammalian cell culture showed that ERK 1/2 associates with
[123] and phosphorylates components of the cytoskeleton [124-126], and it has been
demonstrated that ERK 1/2 negatively regulates tubulin polymerization in Xenopus egg
extracts [108, 115]. Immunodepletion of p42 or pharmacological inhibition of its
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activation causes abnormal mitotic spindles to form in Xenopus egg extracts [115]. As
well, inhibition of ERK 1/2 disrupts formation of the mitotic spindle in mammalian cells
[115] and in sea urchin eggs [116].
It has been suggested that ERK 1/2 regulates spindle assembly through regulation
of a mitotic motor protein CENP-E. CENP-E is necessary for the establishment of
chromosome-microtubule attachment and, therefore, is critical for proper spindle
formation. It has been demonstrated in mammalian cells that CENP-E is a mitotic
substrate of ERK2, which phosphorylates CENP-E on sites that mediate its association
with kinetochores [114].
In cycling Xenopus egg extracts, blockade of mitotic p42 activation shortens the
duration of mitosis [119]. Along with kinetochore localization of ERK 1/2 in mammalian
cells, this data suggests a potential role for ERK in regulation of the SAC. Indeed,
maintenance of an induced spindle assembly checkpoint arrest is compromised in p42
depleted [109] or p42 inhibited [127] Xenopus egg extracts. As well, loss-of-function
mutations in Drosophila’s rolled/MAPK gene caused the abrogation of a colchicine
induced mitotic arrest in Drosophila larvae [128].
Several reports have implicated MAPK in the regulation of SAC. As mentioned
above, the SAC arrest depends on several checkpoint proteins including BubR1, Bub3
and Mad2 binding to Cdc20 to inhibit activation of the anaphase promoting complex
(APC/C). Using Xenopus egg extracts it was shown that during mitotic arrest MAPK
phosphorylates Cdc20 on sites that increase its affinity for BubR1, Bub3 and Mad2 and
negatively regulate the APC/C [129]. Another report demonstrated that MAPK
phosphorylates Mps1, a critical SAC kinase, and this phosphorylation is necessary for
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kinetochore localization of SAC proteins in Xenopus egg extracts [73]. Therefore, it has
been proposed that ERK 1/2 is involved in regulating the SAC.
Supportive of an ERK 1/2 mitotic role in mammalian cells are studies
demonstrating that constitutive activation of MAPK via expression of v-mos or v-ras
expression in mouse fibroblasts causes cells to fail cytokinesis and become binucleated
[130, 131]. This indicates that ERK inactivation is necessary prior to cytokinesis.
However, further studies will be necessary in order to definitively establish that ERK 1/2
regulate this critical mitotic stage.
Fragmentation of the Golgi apparatus during mitosis is an essential process and it
is thought to be a method for partitioning Golgi membranes equally in both daughter cells
[132]. It has been shown that mitotically activated MEK1 (the upstream activator of
ERK1) localizes to Golgi membranes in late prophase [133, 134] and that Raf-1
activation of MEK1 is required for mitotic Golgi fragmentation [133, 135, 136]. Further
studies demonstrated that Golgi fragmentation is mediated through an unusual, truncated
ERK isoform, ERK1c [137, 138]. ERK1c is regulated in an M-phase specific manner,
becoming phosphorylated and localizing to the Golgi during early mitosis [138]. These
findings indicate that activation of ERK 1/2 pathway during mitosis may differ from its
S-phase activation.
In summary, ERK1/2 and their activators, MEK 1/2, localize to key mitotic
structures in Xenopus egg extracts and in cells grown in culture. Functional studies reveal
that ERK 1/2 plays roles in a variety of mitotic functions. While a role for ERK 1/2 in
Golgi fragmentation has been established in mammalian cells, roles in spindle assembly
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formation and the spindle assembly checkpoint have primarily been studied in the system
of Xenopus egg extracts.

B-Raf Kinase
Raf kinases are serine/threonine kinases whose activities regulate a variety of
cellular processes including growth, proliferation, survival, differentiation and apoptosis
[96, 139, 140]. The Raf family consists of A-Raf, B-Raf and C-Raf (Raf-1), which
function as MAP3Ks. Nearly all reported Raf functions result from activation of the
MAPK cascade. Rafs share significant sequence identity and are structurally similar. In
spite of some similarities, Rafs have some significant differences in their regulation,
tissue distribution and developmental functions. While C-Raf is the prototypic Raf
kinase, B-Raf has emerged as the most potent activator of MAPK signaling.

B-Raf Protein Structure
B-Raf, A-Raf and C-Raf share a basic three-domain architecture including
conserved domains, CR1, CR2 and CR3 (Fig. 5). CR1 and CR2 are embedded within the
N-terminal regulatory portion of Rafs, and CR3 resides in the C-terminal kinase domain.
CR1 contains a Ras binding domain (RBD) and a cysteine rich domain (CRD) [141, 142],
both of which provide interacting sites for upstream regulators such as Ras and Rap1
[143]. The CR2 domain contains a negatively regulatory phosphorylation site [144-146]
and a 14-3-3 binding phospho-epitope [147]. The CR3 domain is the kinase domain,
comprised of the N-region and the activation loop, both of which contain phospho-sites
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that regulate Raf activity. Unlike A-Raf and C-Raf, B-Raf contains a unique N-terminal
domain, the significance of which is unknown. While A-Raf and C-Raf genes are
transcribed into one transcript, B-Raf is alternatively spliced, generating several different
B-Raf isoforms [148, 149]. The 95 KD isoform is the largest and most commonly
studied and the significance of the smaller isoforms is not understood.

B-Raf Activation
Raf kinases are activated by similar and distant mechanisms. It is believed that
the N-terminal regulatory domain of Rafs bind to the C-terminal kinase domain, creating
a closed conformation which renders the kinase domain inaccessible for activation [150].
Phosphorylation events and protein-protein interactions disrupts the N-terminal-Cterminal interactions, opening the Raf protein which prepares it for activation [142, 143,
151-155]. However, there are unique aspects to B-Raf’s regulation which explains its
potent MEK kinase activity.
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Fig. 5 Raf family members
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B-Raf requires a lower “dose” of regulatory phosphorylation than does C-Raf for
its activation. Following Ras-mediated stimulation, C-Raf requires two stages of
phosphorylation events including Ras and SRC mediated phosphorylation of Ser-338 and
Tyr-341 in the N-region [156-159] and Ras mediated phosphorylation of Thre-491 and
Ser-494 in the activation loop [140]. B-Raf, however, does not require phosphorylation
within the N-region due to the presence of a constitutive phosphorylation on Ser-335 and
a phospho-mimicking aspartic acid at residue 448 [158]. Therefore, Ras mediated
activation of B-Raf requires phosphorylation of Thr-599 and Ser-602 within the
activation loop [160]. It has been proposed that the constitutive presence of negative
charges in the N-region of B-Raf inhibits the interaction between the regulatory and
catalytic domains, rendering an open conformation [161]. These differences account for
a higher basal level activity in B-Raf than C-Raf.
Rafs are further regulated on the level of protein-protein interactions including
direct interactions with Ras, Rap1 [162-167], MEK [149, 162-167] and C-Raf [168].
While C-Raf and B-Raf both interact with Rap1, Rap1 mediates activation of B-Raf
while it inhibits C-Raf and downstream MAPK signaling [163, 167, 169]. As well, BRaf and C-Raf both directly associate with MEK, however, B-Raf has a higher binding
affinity to MEK than does C-Raf or A-Raf [170], which may account for the fact that BRaf is a stronger activator of MEK than C-Raf or A-Raf [158, 160]. It has also been
shown that B-Raf heterodimerizes with C-Raf, and is required for activation of C-Raf
[171, 172]. While B-Raf/C-Raf heterodimers possess higher kinase activity than both
respective monomers [168], B-Raf can be sufficiently activated by Ras alone [161].
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B-Raf Functions
Analysis of Raf family members in knock-out mice has revealed that A-Raf, BRaf and C-Raf all play essential roles in embryogenesis. Disruption of B-Raf causes
embryonic lethality resulting from apoptotic death of differentiated endothelial cells
[173]. Disruption of C-Raf leads to aberrations in lung development and A-Raf knockout mice generate neurological and intestinal abnormalities [173, 174]. Knock-out
studies also reveal that B-Raf and C-Raf alleles can partially compensate for one another
and exhibit some functional redundancy [174].
Early studies revealed via northern blotting that B-Raf expression was restricted
to tissues of the brain, testes and fetal membranes [175, 176]. However, the use of
improved protein detection techniques demonstrated that B-Raf is ubiquitously expressed
at low levels in most tissues with perhaps highest expression in the brain. Subcellular
localization of B-Raf has exclusively been reported as cytoplasmic, however, a thorough
analysis of B-Raf subcellular localization has yet to be published.
Analyses of B-Raf’s specific cellular functions have been studied either in
comparison with C-Raf and A-Raf, or relative to its oncogenic functions. It was shown
that B-Raf and A-Raf, but not C-Raf exhibit sustained activation by neuronal growth
factor (NGF) in PC12 cells [177], and epidermal growth factor (EGF) activated all three
Raf isoforms. cAMP leads to activation of B-Raf in a Rap1/B-Raf dependent manner in
neurons, whereas C-Raf is inhibited by cAMP [165, 178, 179]. It is widely presumed
that B-Raf functions during S-phase in non-neuronal cells, however B-Raf’s non-
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neuronal functions have not been well studied nor distinguished from the functions of CRaf.

B-Raf as a Mitotic MEK Kinase
It has been shown that ERK is activated during mitosis and contributes to normal
mitotic functions. A recent report from our laboratory demonstrated that B-Raf is the
MAP3K (MEK kinase) responsible for mitotic activation of the MAPK pathway in
Xenopus egg extracts [180]. It was shown that B-Raf is activated in an M-phase specific
manner and is required for the mitotic activation of the MEK/MAPK pathway. As well,
the authors demonstrated that cyclinB-Cdk1 directly phosphorylates B-Raf and
contributes to its activation during mitosis [181], suggesting that B-Raf activation at
mitosis is mediated through mechanisms distinct from those that regulate MAPK
signaling in response to mitogens. Further, it was shown that MAPK regulates B-Raf
through negative feedback phosphorylation, which is presumed to ensure transient
activity of B-Raf during mitosis in Xenopus egg extracts [180].

In summary, B-Raf is a member of the Raf family of kinases, but it stands out due
to its unique structural and functional features. Cumulative evidence from the recent
decade demonstrates that B-Raf is a major activator of the ERK 1/2 cascade. As well,
novel functions have been ascribed to B-Raf. In particular, studies in Xenopus egg
extracts have shown that B-Raf regulates the mitotic activation of MAPK.
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MAPK Pathway in Tumorigenesis
It has long been recognized that the MAPK cascade is a key regulator of cellular
proliferation and survival. Thus, its continuous signaling could lead to cellular
transformation. Indeed, the MAPK pathway is hyperactivated in approximately 30% of
human tumors. Four well studied mechanisms of ERK activation in human tumors
include mutations in the epidermal growth factor receptor (EGFR), Ras, the mitogenactivated protein kinase phosphatases (MKPs) and B-Raf.

EGFR, Ras and MKPs in Human Cancers
The epidermal growth factor (EGF) and its receptor, EGFR [182, 183] signals
through Ras activating the MAPK pathway [184]. It has become well recognized that
EGFR is an oncogene [185-188] and is highly expressed in human cancers and correlated
with poor prognosis [189]. EGFR is frequently overexpressed or mutationally activated
[190] in breast, lung and head and neck cancers, glioblastomas, bladder, colorectal,
ovarian and prostate cancers [191-195]. As well, transforming growth factor alpha
(TGFα), an EGFR’s ligand, is upregulated in a wide variety of transformed cells [196198] thus causing persistent stimulation of EGFR.
Ras proteins are a family of small GTPases that are upstream activators of Rafs
and therefore activators of the MAPK cascade [199]. In normal quiescent cells, Ras is in
its GDP-bound inactive form. Following stimulation by EGF or other factors, Ras is
transformed into its GPT-bound active form which then binds to and stimulates the
activation of Rafs. Ras is converted to its oncogenic form by missense mutations that
render the proteins to be constitutively GTP-bound and active [200]. Since oncogenic
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Ras cannot be inactivated, it drives activation of the Raf-MEK-ERK cascade in a
stimulus-independent manner. Oncogenic Ras occurs in 30% of human tumors including
90% of pancreatic cancers, 50% of colon and thyroid cancers, 30% of lung cancers and
myeloid leukemias, and 15% of melanomas [200-202].
Recently it has come to light that several mitogen-activated protein kinase
phosphatases (MKPs), negative regulators of the MAPK signaling, are involved in
tumorigenesis [203]. MKPs are mutated in tumors of the breast, lung, prostate, ovaries,
pancreas, liver and gastrointestinal tract. Overexpression of several MPKs is observed in
tumors and correlates with poor outcome and progression [204-206], thus serving as a
prognostic marker [207]. However, in several tumors, MKPs are down regulated or
grossly underexpressed [208, 209]. Growth of tumors in nude mice from Ha-ras
transformed cells was greatly delayed when MKP expression was induced, supporting a
tumor suppressor role for MKPs [210]. While the mechanisms of MKP deregulation are
not yet fully understood, it has been shown that hypermethylation leads to loss of MKP-3
expression in pancreatic cancers [211].

B-Raf in Human Cancers
Members of the Raf family were first identified as viral oncogenes causing tumors
in mice and chickens [212-215]. C-Raf activity is increased in response to hyperactivated
EGFR or Ras, however, to date B-Raf is the only Raf kinase that is known to be mutated
in human cancers.
Two decades of testing human tumors for Raf mutations was largely unsuccessful
until a fruitful, high-throughput screen of nearly 1000 human tumor samples identified B27

Raf missense mutations in many human cancers [216]. Activating B-Raf point mutations
were discovered in nearly 70% of melanomas, 40% of papillary thyroid carcinomas [217219]; 14% of ovarian cancers, 14% of liver cancers, 12% of colorectal tumors, 11% of
gliomas, 9% of sarcomas a to a lesser extent in other lymphomas, leukemias, breast, lung
and liver carcinomas, totaling 8% of all tumors sampled [216].
While more than 30 missense mutations were identified, all in the kinase domain
of B-Raf, 80% of the mutations were accounted for by a single Valine to Glutamic acid
substitution at residue 600, B-RafV600E [216]. Melanomas by far accounted for the
highest percentage of B-Raf mutations, in which over 90% of the mutations were
represented with the V600E substitution. Ras mutations account for 15% of melanomas,
however, Ras and B-Raf mutations are mutually exclusive in the vast majority of tumors,
suggesting that Ras and B-Raf transform melanocytes through similar mechanisms. As
well, it has been shown that 80% of benign nevi harbor a B-RafV600E mutation [220],
thereby implicating B-Raf in the early stages of transformation. Additional studies have
shown that a paracentric inversion within chromosome 7 creates a fusion protein between
a portion of the AKAP9 gene and the kinase domain of B-Raf rendering B-Raf
constitutively active [221]. This rearrangement is found at a low frequency (1%) of
sporadic thyroid papillary carcinomas, however its prevalence is 11% among thyroid
papillary carcinomas that developed in children as a result of exposure to radiation from
the Chernobyl explosion. Finally, less commonly noted are B-Raf copy number
amplifications which occur most often in thyroid follicular adenomas (25%) and thyroid
follicular carcinomas (35%) [222].
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B-Raf as an Oncogene
The most common mutation in B-Raf, V600E, is flanked by a threonine at residue
599 and Serine at residue 602, both of which require phosphorylation for Ras mediated
activation [160]. It is therefore conjectured that the negative charge acquired by
substituting glutamic acid for valine suffices as a phospho-mimic capable of activating BRaf [216]. Indeed, the vast majority of mutations in B-Raf were demonstrated to be
activating mutations, with B-RafV600E exhibiting a 10.7 fold increase in its kinase activity
in vitro over wild-type B-Raf. The activating mutations increased endogenous ERK
activation in cell culture, as tested by levels of ERK1/2 phosphorylation, whereas
overexpression of wild-type B-Raf did not increase ERK1/2 phosphorylation [223].
Interestingly, four rare B-Raf mutations found in tumors [216] have reduced in vitro
kinase activity [224] despite activating ERK in cells. It was shown that three of these
exogenously expressed mutants, interact with and activate endogenous wild-type C-Raf,
which then activates ERK [224].
Consistent with its elevated kinase activity, it was shown that B-RafV600E is
capable of inducing transformation in NIH3T3 cells [216] and immortalized mouse
melanocytes [223] in an ERK dependent manner. Further, transformation of melanoma
cells expressing B-RafV600E was reversed upon downregulation of B-Raf [225, 226].
Additionally, it was shown that immortalized melanocytes expressing B-RafV600E form
tumors in nude mice. Consistent with the presence of B-RafV600E mutations in 80% of
benign nevi, transgenic zebrafish expressing B-RafV600E formed benign nevi [227].
However, B-RafV600E induced formation of invasive melanomas in zebrafish, only when
expressed on a p53 deficient background. A conditional B-RafV600E knock-in mouse
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model produces hematopoietic displasia and skin polyps [228]. Transgenic mouse
models targeting B-RafV600E to melanocytes [229] or the lung [230] rapidly develop
benign nevi or adenomas, respectively, but rarely develop melanomas or
adenocarcinomas unless combined with the loss of tumor suppressors Pten, TP53 or
Ink4a/Arf. However, targeted expression of B-RafV600E to the thyroid serves as a tumor
initiator and promoter, resulting in rapid accumulation of parathyroid carcinomas (PTC)
that closely reflect human PTCs [231]. Therefore, B-RafV600E is capable of transforming
immortalized cells and causing benign tumor formation in several animal models.
However, its role in tumor progression varies amongst tumor types, requiring additional
mutations for full transformation to occur.

In summary, MAPK signaling has been implicated in a high percentage of human
tumors. Hyperactivity of the Ras-Raf-MEK-ERK pathway is achieved by mutations on
various levels including the upstream activator EGFR, its ligand, TGFα, activating
mutations in Ras and deregulation of MPKs. Most notably, B-Raf is constitutively
activated in a wide variety of cancers which depend on oncogenic B-Raf expression for
proliferation and survival. 80% of benign nevi harbor oncogenic B-Raf, suggesting that
it is an early transformation event.

Mitosis and Cancer
It has long been recognized that human tumors are genetically unstable.
Nucleotide-level genomic instability and gene mutations are well established causes of
tumorigenesis. However, the form of genetic instability most frequently observed in
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cancers is mitotically driven chromosomal aneuploidy. Mounting evidence supports a
causal role for chromosomal aneuploidy in tumorigenesis, therefore, understanding how
mitosis drives aneuploidy in human tumors has become a critical question of modern
cancer biology.

Types of Genomic Instability
Human disease is largely attributed to genetic alterations [232]. Mutations in
genes which repair or divide the genome cause cells to continuously acquire genomic
changes over time rendering them genomically unstable. The two categories of genomic
instability include nucleotide-level instabilities and mitotically driven aneuploidy [232].
The human genome contains thousands of microsatellites, short sequences of
DNA that are tandemly repeated 10 to 100 times [233]. Microsatellites are highly
susceptible to DNA replication errors, which are repaired by the highly conserved DNA
mismatch repair (MMR). Mutations in MMR genes and occasionally mutations in the
nucleotide excision repair (NER) genes [234] increase the rate of genomic mutations
leading to microsatellite instability (MIN), the most common type of nucleotide-level
genomic instability [232]. MIN occurs in approximately 13% of sporadic colorectal,
endometrial and gastric cancers [235, 236]. It is widely accepted that MIN drives
tumorigenesis [237].
Normal human cells contain 46 chromosomes. Deviation in chromosome number
is referred to as aneuploidy. Gains and losses of whole chromosomes, gene
amplifications and deletions and chromosomal rearrangements and are all forms of
aneuploidy [232, 235, 237]. Embryogenic aneuploidy is typically lethal and when viable,
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causes disease such as Down, Edward and Patau’s syndromes [238]. However, nearly
every tumor cell exhibits aneuploidy and the vast majority of tumor cells are genetically
unstable [239].
Continual chromosomal gains and losses, a form of genomic instability termed
chromosomal instability (CIN), is the most common form of aneuploidy in tumors [232,
237, 239]. Nearly all tumors that do not exhibit MIN are chromosomally unstable, often
containing gross structural changes such as translocations, deletions and amplifications
[237], as determined by classic and modern karyotype analyses. Structural
rearrangements in the absence of whole-chromosomal instability are a well accepted
cause of tumorigenesis, such as the BCR-ABL translocation that drives some cases of
chronic myelogenous leukemias [240]. The role of CIN in tumorigenesis is less well
defined. Some have argued that chromosomal aneuploidy is a side-effect of
tumorigenesis. However, correlative evidence and direct experimental results have
demonstrated that chromosomal aneuploidy contributes to cellular transformation and
cancer development.

Mitosis and Aneuploidy
For well over a century it has been demonstrated that aneuploidy results from
errors in cell division [241]. Some of the mitotic defects which cause aneuploidy include
multipolar spindle formation, defects in chromosome cohesion, spindle-microtubule
misattachments, and a weakened spindle assembly checkpoint [242].
Cells that form multi-polar spindles undergo chromosomal missegregation. It is
believed that multi-polar spindles result from defects in the duplication, segregation and
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maturation of centrosomes. Indeed, Aurora A amplification [243] or inactivation of p53
[244], BRCA1 and BRCA2 [245-248] or mitotic motor protein Eg5 cause errors in
centrosomal duplication or segregation leading to spindle malformation and aneuploid
daughter cells.
Defects in the cohesion of chromosomes have been shown to cause aneuploidy.
Inactivation of securin or separase homologues in budding and fission yeast generates
hypoploidy [249-251]. As well, deletion of securin from human cancer cells induces
high levels of CIN [252].
Another potential mechanism for aneuploidy lies within faulty kinetochoremicrotubule engagement. Merotelic attachments occur upon inhibition of the
chromosomal passenger complex that corrects kinetochore-microtubule attachment errors
[253]. As well, truncated forms of the adenomatous polyposis coli protein generate CIN
by disrupting kinetochore-microtubule attachments [254-256].
An insufficiently performing spindle assembly checkpoint is also implicated in
the production of aneuploidy [257]. Mice with reduced levels of Mad2 [258], BubR1
[259] or Bub3 [260] have a defective SAC and are prone to the acquisition of aneuploidy.
While Mad2, BubR1 and Bub3 have roles throughout the cell cycle, CENP-E functions
exclusively during mitosis [261]. Therefore, it is significant that reduction in CENP-E
levels compromises the SAC and causes aneuploidy in vitro [262] and in mice [263].

Causal Role for Aneuploidy in Tumorigenesis
Aneuploidy is the most common feature found amongst tumors and is considered
a hallmark of cancer [237]. Some of the earliest cancer biologists proposed that
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aneuploidy causes tumorigenesis [264-266]. It is now widely accepted that changes in
gene expression lead to tumorigenesis [267]. Despite arguments that aneuploidy is a
benign consequence of transformation [268], modern biology suggests that mutations in
genes that regulate cell division drive aneuploidy, which is ultimately the means for
generating changes in gene expression that lead to tumorigenesis [232, 235, 269, 270].
Tumor development results from accumulated changes in gene expression. Some
have argued that the accumulation of a few somatic mutations is sufficient to cause
transformation [271]. However, mathematical modeling predicts that the acquisition of
sufficient numbers of changes cannot be achieved solely by the acquisition of
spontaneous mutations [272]. Mathematical models also predict that the onset of
genomic instability is an early and necessary event in tumor development [235]. In fact,
allelic loss occurs in extremely small polyps in early stage colorectal cancers [273], and
aneuploidy is present in precancerous lesions of the cervix, head and neck, esophagus and
bone marrow [274]. Human tumors gain and lose chromosomes at a rate of 10-100 times
higher than normal cells [239]. Average tumors of the colon, prostate and breast have
lost 25% of their alleles [232] and exhibit heterogeneity due to continual genomic
changes [275].
It has been demonstrated that a large number of CIN colorectal tumors cannot
adequately activate their spindle assembly checkpoint [276]. In fact, a large proportion
of human tumors display misexpression of genes that regulate the SAC. BubR1 and
Mad1 are frequently misregulated in a number of human cancers [261]. Mad2 was
found to be transcriptionally overexpressed in several tumor types including
hepatocellular, lung and intestinal carcinomas, B cell lymphomas and several others
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[277]. Mutational inactivation of Bub1 or BubR1 have been observed in colon cancers
[276]. Several tumor types, including pituitary adenomas and mammary and pulmonary
adenocarcinomas, exhibit overexpression of securin [278-280]. Other genes that regulate
mitosis such as Apc, BRCA1 and BRCA2 are misregulated in a number colorectal,
duodenal, breast, ovarian, colon and pancreatic cancers [261].
Direct evidence has demonstrated that aneuploidy can drive tumorigenesis. In
2007, it was reported that cells from Mad2 transgenic mice become highly aneuploid and
develop a wide variety of tumors including liver and lung carcinomas, sarcomas and
lymphomas [277]. The mice developed whole chromosomal aneuploidy and structural
chromosomal abnormalities, as shown by g-banding analysis. Immunofluorescence
studies demonstrated that Mad2 cells exhibit lagging chromosomes and chromosome
bridges during mitosis – a strong indication that mitotic errors were the driving factor
behind the acquisition of aneuploidy. As well, it was shown that transient Mad2
expression is sufficient for long-term tumor development, suggesting that aneuploidy
induced by Mad2, rather than Mad2 itself, was necessary for tumor maintenance.
Further direct evidence that aneuploidy is tumorigenic comes from studies in mice
with reduced CENP-E levels [263]. These studies are particularly significant since the
role of CENP-E is exclusively relegated to mitosis. Mice heterozygous for CENP-E
exhibit whole chromosomal aneuploidy, in the absence of structural abnormalities, as
shown by spectral karyotyping. Lagging and pole-associated chromosomes were
detectable in 40% of cells isolated from CENP-E heterozygous mice, implicating mitotic
errors as the cause of aneuploidy. After a long latency period, these mice develop
splenic lymphomas and lung adenomas at a rate of 10%, comparable to the number of
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smokers who develop lung cancer. The long latency period indicates that a small subset
of the aneuploid cells have the potential to drive transformation. In the presence of other
aneuploidy-inducing carcinogens, CENP-E heterozygous mice had a reduced incidence
of tumorigenesis, indicating that a significantly high level of aneuploidy is incompatible
with life [261].

In summary, mitosis must be accurately executed in order to preserve the genomic
integrity of a cell. Mitotic proteins, whose misregulation drives aneuploidy in vitro, are
frequently misexpressed in human tumors. Nearly all tumors are aneuploid and
genomically unstable from an early stage in tumor development and the degree of
aneuploidy is directly correlated with the stage of tumorigenesis. As well, direct studies
of Mad2 and CENP-E confirm that mitotically induced aneuploidy is tumorigenic in
mice. Together, these observations support the assertion that misexpression of spindle
assembly proteins promote aneuploidy, which can contribute to tumorigenesis.
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Hypothesis and Dissertation Statement

Recently, it has come to light that B-Raf is a prominent oncogene, mutated in a
wide spectrum of tumors including nearly 70% of melanomas. Oncogenic B-Raf is also
expressed in 80% of benign nevi, indicating that it plays an early role in tumorigenesis. It
is crucial to understand the molecular mechanism by which oncogenic B-Raf contributes
to tumorigenesis. The cellular mechanisms through which oncogenic B-Raf may drive
transformation are beginning to be appreciated. However, more work is needed in order
to understand the full effects of oncogenic B-Raf.
It is well accepted that B-Raf is the most potent activator of MAPK signaling
[158, 160]. The MAPK pathway is a critical signal transduction pathway necessary for
cellular proliferation, cell survival, stress response and apoptosis [93]. MAPK signaling
is also involved in the regulation of mitosis [108-110, 113, 114, 119, 134]. Interestingly,
B-Raf has been reported to activate MAPK signaling during mitosis in Xenopus egg
extracts [180], however, little is known about B-Raf functions in human cells. I
hypothesize that B-Raf regulates mitotic functions in human somatic cells and that
oncogenic B-Raf disrupts mitosis, leading to aneuploidy.
To address these hypotheses, I conducted loss-of-function experiments in cell
cultures in order to evaluate the contribution of B-Raf to mitosis. Further, I introduced
oncogenic B-Raf into cancer, immortalized, and primary cells, evaluating the cells
mitoses and analyzing their karyotypes.
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The results of my thesis work demonstrate that B-Raf regulates several critical
mitotic functions and that oncogenic B-Raf perturbs mitosis, driving aneuploidy and
chromosomal instability.
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CHAPTER 2
SUBCELLULAR B-RAF LOCALIZATION

Introduction
Regulatory functions of MAPK signaling are mediated in large part by the
subcellular localization of MAPK pathway members. Active forms of MEK and ERK
localize to the cytoplasmic compartment in order to phosphorylate substrates localized at
the cytoskeleton structures and they translocate into the nucleus to regulate gene
expression by phosphorylating transcriptional factors [281, 282]. During mitosis, active
MEK and ERK colocalize to the mitotic spindle poles, the kinetochores, the midzone of
the anaphase spindle and the telophase bridge during cytokinesis [112]. Little has been
published on the subcellular localization of B-Raf with the exception of its localization
throughout the cell body of post-mitotic neural cells [283].
B-Raf is itself regulated by phosphorylation events. Ras mediated activation of
B-Raf requires phosphorylation on two key residues (Ser 599 and Thr 602) in B-Raf’s
kinase domain. Evaluating the localization of dually phosphorylated B-Raf can give
clues to the cellular positioning of active B-Raf.
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Results
B-Raf Localizes to Mitotic Structures
MEK and ERK, members of the MAPK signaling cascade, localize to mitotic
structures when activated by phosphorylation. Work from our laboratory has revealed
that B-Raf is critical for mitotic activation of the MAPK cascade and its activity is
regulated in an M phase-dependent manner [180]. Therefore it stands to reason that BRaf might also exhibit mitosis-specific localization.

B-Raf is Detected at the Mitotic Spindle
In order to test whether B-Raf localizes to the mitotic spindle apparatus,
immunofluorescence studies were carried out in cycling NIH 3T3 cells (Fig. 6), MCF-7
cancer cells (data not shown) and human foreskin fibroblast (HFF) cells (Fig. 7) using a
monoclonal alpha-tubulin antibody to stain the mitotic spindle, DAPI to visualize the
chromosomes and a commercially available, polyclonal antibody against B-Raf. This
antibody recognizes a single, 95 kD protein band in corresponding cellular lysates (data
not shown). B-Raf was exclusively detected in the cytoplasmic compartment of
interphase cells. Interestingly, as shown in HFF cells, at the onset of mitosis or prophase
(as determined by chromosome condensation and aster formation), B-Raf localizes to the
nuclear region. As cells enter metaphase, B-Raf becomes highly enriched in the region of
the mitotic spindle and the spindle poles and to the spindle and midzone during anaphase.
This was most evident upon utilizing a threshold analysis, which distinguishes the areas
containing the highest relative levels of B-Raf staining. In late telophase and cytokinesis,
the B-Raf staining pattern was mostly confined to the cytoplasmic compartment, as it was
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Figure 6. B-Raf localizes to the mitotic spindle in NIH 3T3 cells
a. Immunofluorescence staining of endogenous B-Raf protein. a. B-Raf; b
threshold analysis depicting regions of strong B-Raf enrichment; c. overlay
α-tubulin to visualize the spindle (red) and DNA (blue); Images were
acquired at 100X magnification, scale bar represents 3µm, arrows depict
mitotic cells.
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Fig. 7 B-Raf localizes to the mitotic spindle in HFF cells
Top Panel: Immunofluorescence in asynchronous HFF cells of endogenous BRaf protein (green) Bottom Panel: Overlay of B-Raf threshold (green), αtubulin (red) and DNA stained with DAPI (blue). Images were acquired at
100X magnification.

42

during interphase. The enrichment of B-Raf staining at the metaphase spindle region was
also observed using a mouse monoclonal B-Raf antibody, indicating that the staining
pattern from the two antibodies reflects the detection of B-Raf protein. Neither the
isotype control for the polyclonal (Rabbit IgG) nor monoclonal (Mouse IgG2b) generated
any appreciable staining pattern.
To further ascertain whether B-Raf’s mitotic staining co-localizes to microtubule
spindle structures, I used confocal microscopy to acquire 0.45 μm z-sections throughout
HFF cells. The results demonstrate that B-Raf staining was restricted to the confocal
sections containing spindle microtubules and condensed chromosomes (Fig.8). Strong BRaf staining appears at the spindle poles and the spindle midzone in cells undergoing
metaphase and anaphase, respectively. Viewing metaphase cells down the spindle pole
axis permits us to visualize B-Raf along the radial microtubules and at the spindle poles.
Thus, B-Raf localization is enriched at the spindle apparatus during mitosis in somatic
tissue culture cells.

B-Raf Interacts with Spindle Microtubules
Immunofluorescence staining demonstrates that B-Raf is enriched at the region of
the mitotic spindle, and therefore B-Raf may be directly associated with the microtubules
of the spindle apparatus. In order to address this question, entire z-series of
immunofluorescence images of B-Raf and the mitotic spindle were analyzed with Imaris
Bitplane 3D blind deconvolution followed by processing with the ImarisColoc module to
isolate, visualize and quantify region overlap. These analyses demonstrated that a portion
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Figure 8. B-Raf is detected at the spindle apparatus during mitosis in HFF
cells
Confocal microscopy of HFF cells stained with antibodies against endogenous
B-Raf (red), α-tubulin to visualize the spindle (green) and DNA stained with
DAPI (blue). Images represent 0.48µm along the z-axis from within a z-series.
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of B-Raf directly colocalizes with the polymerized microtubules of the spindle (Fig. 9),
suggesting that B-Raf directly interacts with the spindle microtubules.
In order to validate the Imaris data, HFF and HeLa cells were exposed to
nocodazole in order to depolymerize the microtubules. Cells were stained with tubulin
and B-Raf antibodies and the B-Raf staining pattern was assessed by fluorescence
microscopy. As shown in Figure 10, the staining pattern of B-Raf corresponding to the
metaphase spindle was radically altered upon nocodazole treatment indicating that B-Raf
localization at metaphase reflects its association with the spindle microtubules.
Based on the same principals of nocodazole function, we performed a
biochemical experiment in Xenopus egg extracts to determine if B-Raf interacts with
polymerized microtubules during mitosis and if the interaction is disrupted when
microtubules are depolymerized by nocodazole. As shown in Figure 11, B-Raf and
polymerized microtubules are associated in a pelleted fraction of egg extracts and the
association is decreased when microtubules are depolymerized with nocodazole.

B-Raf Localizes to the Centrosomes
Based on the immunofluorescence threshold analyses and confocal data
demonstrating an abundance of B-Raf at the spindle poles during mitosis, I decided to
analyze mitotic cells for B-Raf colocalization to the centrosome. The centrosome is
comprised of an abundance of proteins concentrated into two centrioles. The centrosome
and its associated proteins can be detected following a brief detergent extraction of
soluble proteins. NIH 3T3 or HFF cells were briefly extracted with CHAPS
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Fig. 9 B-Raf interacts with the spindle microtubules
in HFF cells
Confocal images of B-Raf and the spindle were
analyzed using Imaris Bitplane 3D blind deconvolution.
Following deconvolution, resulting stack was processed
with ImarisColoc module to isolate, visualize and
quantify region overlap. Green represents α-tubulin, red
is background B-Raf staining and yellow represents
areas where B-Raf and microtubules interact.
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Fig. 10 B-Raf spindle localization is disrupted when microtubules are
depolymerized with nocodazole
HFF and HeLa cells were treated for two hours with nocodazole to induce
destabilization of microtubules. Cells were fixed with 4% paraformaldehyde
and processed for immunostaining of B-Raf (green) and α-tubulin (red), and
DAPI was used to detect DNA (blue). D=DMSO; N=Nocodazole.

47

Fig. 11 B-Raf co-pellets with microtubules isolated
from M phase Xenopus egg extracts
Spindle microtubules structures formed in mitotic
Xenopus egg extracts, in the absence or presence of 10
ng/μl nocodazole, were pelleted through a 40%
glycerol buffered cushion as previously described
(Horne Guadagno, 2003). The microtubule pellet and
its associated proteins were resuspended in SDS
sample buffer, separated by 10% SDS-PAGE, and
subjected to immunoblot analysis for α-tubulin and BRaf.
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detergent, fixed with 4% paraformaldehyde, stained for B-Raf, tubulin and DAPI to
visualize the chromosomes. The results showed that throughout the cell cycle the
majority of B-Raf was removed by CHAPS extraction with the exception of two discrete
pairs of foci on opposite sides of the aligned chromosomes, a distinct centriolar staining
pattern (Fig. 12). To confirm that B-Raf colocalizes directly with the centrioles, cells
were costained with B-Raf and centrin, a centriole marker, followed by confocal analysis
of 0.45 μm Z-sections. Both pairs of foci co-localized precisely with centrin in both
NIH3T3 (Fig. 12) and HFF (Fig. 13) cells during mitosis. As shown in Fig. 14, B-Raf is
present at the centrosome throughout the cell cycle. Hence, we conclude that a detergentresistant pool of B-Raf is tightly associated with the centrioles in mammalian cells.

B-Raf is Phosphorylated on Serine 599 and Threonine 602 at Mitotic Structures
B-Raf is dually phosphorylated at conserved residues Thr599 and Ser602 during
Ras-mediated activation (Zhang and Guan, 2000), therefore dual phosphorylation of BRaf suggests that B-Raf is active and capable of phosphorylating downstream targets. To
determine whether B-Raf is phosphorylated at these two residues during mitosis, HFF
cells were subjected to immunostaining with a monoclonal alpha-tubulin antibody, a
phospho-B-Raf (Thr599/Ser602) antibody and DAPI to visualize the DNA.

Phosphorylated B-Raf Localizes to the Centrosomes
During interphase, phospho-B-Raf (Thr599/Ser602) staining was weakly visible
at the centrosome and the remainder of the cells is devoid of phospho-B-Raf staining,
however, a notable staining pattern of phospho-B-Raf (Thr599/Ser602) was detectable
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Figure 12 B-Raf localizes to the centrosomes in NIH 3T3 cells
Immunofluorescence of endogenous B-Raf protein. Cells were incubated with 1% CHAPS containing buffer, prior to
fixation, in order to wash away soluble proteins and retain insoluble proteins and proteins tightly associated with
insoluble structures. Cells were stained with antibodies against endogenous B-Raf (green), centrin to visualize the
centrosome (red) and DNA (blue). Images were acquired at 100X magnification, scale bar represents 3µm. Centrioles
are magnified 4X in the outset panel.
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Figure 13 B-Raf localizes to the centrosomes in HFF cells
Immunofluorescence of endogenous B-Raf protein. Cells were incubated with 1% CHAPS containing
buffer, prior to fixation, in order to wash away soluble proteins and retain insoluble proteins and proteins
tightly associated with insoluble structures. Cells were stained with antibodies against endogenous B-Raf
(green), centrin to visualize the centrosome (red) and DNA (blue). Images were acquired at 100X
magnification. Centrioles are magnified 5X in the outset panel.
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Figure 14 B-Raf localizes to the centrosomes throughout the cell cycle
Immunofluorescence of endogenous B-Raf protein. Cells were incubated with 1% CHAPS
containing buffer, prior to fixation, in order to wash away soluble proteins and retain
insoluble proteins and proteins tightly associated with insoluble structures. Cells were stained
with antibodies against endogenous B-Raf (green), α-tubulin to visualize the spindle (red) and
DNA (blue). Images were acquired at 100X magnification.
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during all stages of mitosis (Fig. 15). At prophase, the onset of mitosis, strong phosphoB-Raf staining was detectable at the centrosomes and remained at the spindle poles
throughout metaphase and anaphase. This staining pattern was nearly identical to the
non-phosphorylated B-Raf centrosomal staining. Additionally, phospho-B-Raf
(Thr599/Ser602) staining was detected at the spindle midzone in cells undergoing
anaphase and, at the midbody in late telophase cells undergoing cytokinesis.
Collectively, these results indicate that pools of active B-Raf localize to specific spindle
structures including the centrosomes during cell division.

Phosphorylated B-Raf Localizes to Condensed Chromatin
While phospho-B-Raf (Thr599/Ser602) staining was exclusively detected at the
centrosome during interphase, staining became prominent at the nuclear region
containing condensed chromosomes during prophase, in agreement with the staining
pattern for total B-Raf protein (Fig. 7). During metaphase, phospho-B-Raf
(Thr599/Ser602) staining was concentrated at regions surrounding the aligned
chromosomes (Fig. 15). The perichromosomal space is the region that directly encircles
each condensed chromosome. Many proteins localize to the perichromosomal space
during mitosis and the functions of these proteins and the perichromosomal region have
not been fully defined. However, it has been shown that several components that localize
to the perichromosomal space are involved in mitotic functions such as chromosome
condensation, decondensation, mitotic progression, cytokinesis and nuclear envelope
reformation following exit from mitosis. In order to directly address whether B-Raf is
phosphorylated in a perichromosomal fashion, chromosomes were isolated from
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Figure 15 B-Raf is phosphorylated at key mitotic structures
HFF cells were immunostained for phospho-B-Raf using a phospho-B-Raf
(Thr599/Ser602) antibody (b.). Microtubules and DNA (a.) were detected with
anti-α-tubulin antibody and DAPI. Images were captured at 100X magnification.
Overlay is shown in c and d - d is magnified 4X. Scale bar represents 10 μm.
Arrows point to the centrosomes and the midbody.
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Figure 16 Phosphorylated B-Raf localizes to the condensed chromosomes
Phospho-B-Raf (Thr599/Ser602) localizes to the perichromosomal space during metaphase, but
not interphase. Chromosomes were isolated from HeLa cells treated with nocodazole for 2 hrs
and subjected to immunostaining and visualized with confocal microscopy. Kinetochores were
visualized with CREST antiserum (red); green foci represent phospho-B-Raf staining. Shown
are single 0.45 μM sections from within a z-series of a metaphase cell. A metaphase cell is
shown in the center of each panel surrounded by three interphase cells, in which no
colocalization is observed.
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Figure 17 Phosphorylated B-Raf localizes to the perichromosomal sheath
Phospho-B-Raf (Thr599/Ser602) localizes to the perichromosomal sheath
during metaphase, but not interphase. Images from figure 18 were analyzed
using Imaris doconvolution software and a 3D isosurface model was rendered.
Kinetochores were visualized with CREST antiserum (red); green foci
represent phospho-B-Raf and chromosomes are shown in blue (DAPI). A
metaphase cell is shown in the center and an interphase cells, in which no
colocalization is observed, to the bottom left of the panel. Joseph Johnson
created this image.
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interphase and metaphase cells, spun onto coverslips and stained with DAPI and the
phospho-B-Raf antibody. Confocal microscopy revealed that phospho-B-Raf
(Thr599/Ser602) encircles each individual chromosome during metaphase, whereas no
chromatin associated staining was detected in interphase cells (Fig. 16). The
perichromosomal staining is further supported by rendering a three-dimensional
isosurfacing model of the chromosomes (Fig. 17).

Phosphorylated B-Raf localizes to the Kinetochores
Confocal imaging of B-Raf staining in HFF cells revealed discrete foci detectable
along the metaphase plate of aligned chromosomes (Fig. 8, metaphase) reminiscent of
kinetochores. A view along the spindle pole axis (Fig. 8, metaphase y-axis) showed these
foci appeared as a ring-like structure that co-localized at the juncture where spindle
microtubules meet the aligned chromosomes, typically the site of the kinetochores. Close
inspection phospho-B-Raf (Thr599/Ser602) staining revealed the appearance of foci
overlapping with chromosomes during metaphase and anaphase (Fig. 15, row d). To
determine whether these foci were localized at kinetochores, metaphase chromosomes
were isolated from nocodazole-treated HFF cells, fixed and adhered to coverslips.
Chromosomes were subjected to immunofluorescence analysis. Co-staining with the
kinetochore marker CREST antiserum and phospho-B-Raf showed that phospho-B-Raf
foci overlap directly with every pair of kinetochores of metaphase chromosomes (Fig. 18,
metaphase). In contrast, interphase nuclei demonstrated no kinetochore colocalization of
phospho-B-Raf (Fig. 18, interphase). These results demonstrate that phospho-B-Raf
(Thr599/Ser602) co-localizes with the kinetochores during metaphase.
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Figure 18 Phosphorylated B-Raf localizes to the kinetochores during mitosis
Phospho-B-Raf (Thr599/Ser602) stained foci co-localize to kinetochores at metaphase, but not
interphase, chromosomes. Chromosomes were isolated from HeLa cells treated with
nocodazole for 2 hrs and subjected to immunostaining and visualized with confocal
microscopy. Kinetochores were visualized with CREST antiserum (red); green foci represent
phospho-B-Raf staining. Shown are single 0.45 μM sections from within a z-series of a
metaphase cell.
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Conclusions
Prior to my studies, reports on the subcellular localization of B-Raf were limited
strictly to the cytoplasm of interphase neurons. My results demonstrate that B-Raf
localization and phosphorylation is cell-cycle specific. Specifically, B-Raf localizes to
and is phosphorylated at mitotic structures, many of which are known to play a critical
role in the accuracy and timing of mitosis.
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CHAPTER 3
B-RAF PERFORMS CRITICAL MITOTIC FUNCTIONS

Introduction
Previous studies from our laboratory show a role for MAPK in promoting the
formation and stability of the mitotic spindle [115]. Specifically, blocking MEK activity
or depleting p42 MAPK from Xenopus egg extracts inhibits spindle assembly and leads
to the generation of aberrant half spindles, a portion with unfocused poles, and
microtubule (MT) asters. Moreover, when mammalian cells are treated during late G2
and M phases with the pharmacological MEK inhibitor U1026, a high frequency of
spindle abnormalities and misaligned chromosomes is observed indicating that MEK
signaling is also important for spindle functions in somatic cells. A role for B-Raf in
activating the MAPK cascade during mitosis has been suggested from studies in Xenopus
egg extracts that mimic the early embryonic cell cycles of S and M phases [180]. As
well, it has been reported that peaks of B-Raf activity are detected at M phase and early
G1 phase during the cell cycle of HeLa cells [134], but hard evidence for B-Raf having a
role in regulating mitosis in somatic cells had not been described. The studies described
in this chapter show evidence for mitotic functions of B-Raf at mitosis in human somatic
cells.
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Results
B-Raf Contributes to Mitotic Spindle Assembly in Xenopus Egg Extracts
Work from our laboratory has shown that proper mitotic spindle assembly in
Xenopus egg extracts requires ERK phosphorylation. In the same system, we have
shown that B-Raf is the MEK kinase which activates ERK signaling during mitosis. BRaf and ERK activities do not regulate S-phase functions in Xenopus egg extracts, as they
are strictly relegated to mitosis. These data suggests that B-Raf may regulate spindle
assembly in Xenopus egg extracts through direct effects on mitosis.

Spindle Assembly is Compromised in the Absence of B-Raf in Xenopus Egg Extracts
Xenopus egg extracts are a powerful biochemical system for studying the
regulation of spindle assembly. Antibodies can be used to efficiently immunodeplete
endogenous proteins and spindle assembly can be monitored. As shown in figure 19, BRaf protein in Xenopus CSF-arrested egg extracts is immunodepleted using B-Raf
antibodies but not rabbit IgG mock control. Metaphase spindle formation was monitored
by the addition of rhodamine labeled tubulin in both mock- and B-Raf-depleted extracts.
Formation of spindles in mock-depleted egg extracts occurred properly, as shown,
exhibiting bipolar spindles with focused poles and well-organized microtubules (Fig. 20).
In contrast, the depletion of B-Raf from egg extracts disrupted spindle assembly, resulted
in unfocused spindle poles and splayed spindle structures. Several monopolar, half
spindle structures were also formed as well as structures lacking organized microtubules
and containing misaligned chromosomes. These results indicate that B-Raf is required
for mediating proper spindle assembly in Xenopus egg extracts.
61

Figure 19 Immunodepletion of B-Raf from
Xenopus egg extracts
CSF-arrested Xenopus egg extracts were depleted of
endogenous B-Raf protein with B-Raf specific
antibodies. Extracts were activated into S phase (S)
with 0.4 µM Ca+2 addition and cycled into M phase
(M) with nondegradable cyclin B.

Figure 20 B-Raf contributes to spindle assembly
in Xenopus egg extracts
Extracts were prepared as in figure 20. Rhodamine
labeled α-tubulin was added to visualize spindle
assembly and DNA was stained with Hoechst buffer.
Images were taken on 100X magnification.
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B-Raf is Necessary for Spindle Formation and Chromosome Congression in Human
Somatic Cells
Our preliminary studies in Xenopus egg extracts suggest a role for B-Raf in the
regulation of mitotic spindle assembly. Immunofluorescence data suggests that active
forms of B-Raf reside at mitotic structures in human somatic cells. Therefore I
investigated whether B-Raf regulates the assembly of the mitotic spindle in human
somatic cells.

Knockdown of B-Raf by siRNA Inhibits Proper Spindle Formation and Chromosome
Congression
To determine if B-Raf regulates spindle assembly in human somatic cells, two
independent 21-base pair RNA duplexes corresponding to conserved B-Raf sequences in
exon 11 (BE11), and exon 3 (BE3) were utilized to downregulate B-Raf . Spindles of
mitotic cells were subsequently analyzed via immunofluorescence microscopy. siRNAs
were transfected individually into human foreskin fibroblast (HFF) cells and HeLa cells
(data not shown). A 21-base pair scrambled sequence was used as a control.
Transfection of the BE11 or BE3 siRNAs led to an 80-95% reduction of B-Raf protein
levels in HFF cells within 72 hours as assessed by immunoblot (Fig. 21). The scrambled
control siRNA had no apparent effects on spindle morphology (Fig. 22). However,
knockdown of B-Raf with the BE11 or BE3 siRNA resulted in pleiotropic spindle
abnormalities in 80-90% of the mitotic cells analyzed from at least eight independent
experiments. Three general groups of abnormal spindle phenotypes were observed: 49%
with abnormal spindle morphology, including unfocused poles, 29% with shortened
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spindle structures, and 22% with microtubule bundles. In the scrambled control cells,
chromosome congressed in an organized, linear fashion at the metaphase plate in nearly
90% of cells. In contrast, chromosome alignment at the metaphase plate was perturbed in
the vast majority of B-Raf depleted cells. Cells exhibited chromosomes throughout the
region of the metaphase plate, along the perimeter of the mitotic spindle structures, at the
spindle poles, and encircling entire spindle structures. Thus, our data suggest that B-Raf
is critical for proper spindle formation and chromosome congression in human somatic
cells.

C-Raf is Dispensable for Normal Spindle Assembly
Previous studies suggested that C-Raf (Raf-1) might play a cell cycle role at the
G2/M transition [118, 284, 285]. Therefore, we also examined the consequences of
reducing C-Raf protein levels in HFF cells. We transfected a 21-base pair RNA duplex
(siRNA) specifically targeting C-Raf into human foreskin fibroblast (HFF) cells. A 21base pair scrambled sequence was used as a control. Transfection of HFF cells with the
C-Raf specific siRNA led to an 85% or greater reduction of C-Raf, but not B-Raf, after
48-72 hr (Fig. 23, A). In contrast to the phenotypic abnormalities generated in B-Raf
knockdown cells, spindle morphology and chromosome alignment appeared completely
normal in C-Raf depleted HFF cells as evaluated by immunofluorescence microscopy
(Fig. 23, B). Thus, we conclude that C-Raf is not required for proper spindle formation
or chromosome congression in somatic tissue culture cells.
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Figure 21 Downregulation of B-Raf by siRNAs
HFF cells were transfected with scrambled siRNA
(SCR) or siRNAs targeting sequences within
exons 11 or 3 of B-Raf (BE11 or BE3,
respectively) and analyzed 48-72 hours posttransfection. Western analysis probing for B-Raf
or α-tubulin (loading control).

65

Figure 22 B-Raf contributes to proper spindle assembly in human somatic cells
HFF cells were transfected with scrambled siRNA (SCR) or siRNAs targeting B-Raf (BE11 or BE3) and
analyzed 72 hours post-transfection. Photos are representative of typical abnormalities observed in spindle
(red) morphology and chromosome (blue) congression. 50-100 spindle structures were analyzed in each of
8 experiments for each siRNA. Images were acquired at 60X magnification; scale bar represents 5 μM.
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A.

B.

Figure 23 C-Raf is not necessary for assembly of
the mitotic spindle
Knockdown of C-Raf by siRNA has no effect on
spindle assembly or DNA alignment. HFF cells were
transfected with a scrambled control siRNA (SCR), BRaf specific siRNA, or C-Raf specific siRNA and
analyzed 72 hours post-transfection. (A) Western
analysis probing for C-Raf or α-tubulin (loading
control). (B) Mitotic spindle and DNA alignment
appear normal in C-Raf-depleted cells transfected with
siRNA. Results are representative of at least three
independent experiments. Images were acquired at
60X magnification; scale bar represents 5 μM.
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B-Raf Regulates Microtubule-Kinetochore Engagement
Metaphase is the stage of mitosis during which chromosomes align in the
metaphase plate, equidistant from each centrosome, a process termed chromosome
congression. Chromosome congression is preceded by and dependent upon the bipolar
attachment of spindle microtubules to the kinetochores of each chromosome, otherwise
known as “microtubule-kinetochore engagement” or “microtubule capture”. Microtubule
capture depends on the coordination of proteins which localize to the kinetochores.
Following the downregulation of B-Raf, cells exhibit aberrancies in both spindle
assembly and chromosome congression. One explanation for the lack of chromosome
congression could be that microtubule-kinetochore engagement is impaired in the
absence of B-Raf. The localization data demonstrates that B-Raf localizes to and is
phosphorylated at the kinetochores, suggesting that B-Raf may indeed play a role in
kinetochore mediated functions.

CENP-E Levels are Elevated at the Kinetochores in the Absence of B-Raf
In order to determine whether the microtubules and kinetochores are engaged
following siRNA downregulation of B-Raf, cells were analyzed for the presence of an
engagement marker. The CENP-E motor protein is essential for microtubule capture by
kinetochores and for regulating subsequent microtubule-kinetochore dynamics [286]. It
has also been established that the levels of CENP-E bound to the kinetochores during
early mitotic stages is increased three to five fold when microtubules are unattached to
kinetochores [286]. While the significance of this increase is not fully understood,
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kinetochore associated CENP-E levels serve as a marker of microtubule-kinetochore
engagement.
HeLa and HFF cells were transfected with B-Raf or scramble control siRNAs as
previously described. 72 hours post-transfection, it was determined that the B-Raf
knock-down cells exhibited the aforementioned phenotypic abnormalities. A
corresponding set of scrambled control and B-Raf knock-down cells were subjected to
immunostaining for CENP-E and the kinetochore marker, CREST. Cells were imaged
via confocal microscopy and 3-dimentional z-series projections were used to quantify the
CENP-E colocalized with the kinetochores. While CENP-E was present at the
kinetochores in the scrambled control cells, levels of kinetochore bound CENP-E
increased by an average of 3.8 fold in cells transfected with the B-Raf siRNA (Fig. 24).
The B-Raf knock-down cells that were analyzed exhibited chromosomal misalignment.

Microtubules are not Cold Stable in the Absence of B-Raf
Cells transfected with B-Raf siRNA display misaligned chromosomes and have
elevated CENP-E, a marker for impaired microtubule capture. Microtubule
polymerization from tubulin dimers is a dynamic and reversible process. Polymerized
spindle microtubules are cold-stable when the microtubule’s plus ends are attached to
kinetochores and conversely they are cold-labile when unengaged. The classic
experiment to directly assess whether spindle microtubules are engaged with
kinetochores is to perform a cold-microtubule depolymerization assay.
To do this, I downregulated B-Raf using siRNA as described above and cells
subsequently were plated on coverslips in tissue dishes. 72 hours post- transfection,
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Figure 24 Kinetochore bound CENP-E levels following
downregulation of B-Raf
Quantitation of CENP-E bound to the kinetochores. (A) HeLa cells
were transfected with a SCR control siRNA or siRNA targeting B-Raf
(BE11) and 72 hours post-transfection cells were stained for DNA (blue),
kinetochore (red), CENP-E (green). (B) CENP-E that localizes directly
with kinetochores was quantified.

70

the tissue culture dishes on which the cells were plated were subjected to cold by
incubation on ice for several minutes. Cells were then fixed, stained for alpha-tubulin
and DNA, and their microtubules were analyzed by immunofluorescence microscopy.
The scrambled control cells exhibited normal chromosome congression spindle assembly
(Fig. 25). Following cold treatment, the microtubules of the control cells remained
polymerized. (The cells exhibited the anticipated morphological changes associated with
cold). The cells in which B-Raf was transfected exhibited misaligned chromosomes and
abnormal spindles. When subjected to cold treatment nearly 100% of these microtubules
underwent complete and rapid depolymerization, thus demonstrating an absence of
kinetochore-microtubule engagement in these cells.
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Figure 25 Microtubules are not cold-stable in the absence of B-Raf
HFF cells were transfected with a scrambled siRNA (siSCR) or a B-Raf targeting siRNA (siBRaf). 72 hours post-transfection cells were exposed to ice for 10 minutes to depolymerize
unengaged microtubules. Cells were then fixed with 4% paraformaldehyd and stained for DNA
(blue) and α-tubulin (green). B-Raf depleted cells retained few to no polymerized microtubules,
demonstrating that those cells had few to no microtubules engaged with kinetochores.
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B-Raf Regulates the Spindle Assembly Checkpoint
The spindle assembly checkpoint (SAC) arrests cells in mitosis prior to anaphase
until all sister chromatid pairs are attached at the mitotic spindle. Activation of the SAC
is dependent upon the activities of proteins which localize to the kinetochores. B-Raf
itself localizes to and is dually phosphorylated at the kinetochores exclusively during
mitosis. B-Raf depleted cells generate abnormal spindle structures and misaligned
chromosomes and have deficiencies in microtubule-kinetochore engagement. Regardless
of such dramatic mitotic defects, B-Raf depleted cells continue to proliferate over a 3-4
day period similar to control cells treated with scrambled siRNA. Therefore, we asked
whether the spindle assembly checkpoint is functional in cells that are lacking B-Raf.

Cells Cycle through Mitosis in the Absence of B-Raf
It is anticipated that cells will arrest in mitosis if they have defects in spindle
assembly. To address whether B-Raf depleted cells arrest at the spindle assembly
checkpoint, control and B-Raf depleted cells were counted and scored as being in
interphase or mitosis based on their flattened or rounded morphology, respectively. The
percentage of rounded cells following B-Raf downregulation was not significantly
increased over cells in the control group (Fig. 26, A).
Cyclin B levels peak during metaphase and drop off rapidly to initiate anaphase,
therefore Cyclin B levels serve as a biochemical marker of mitosis, specifically of
metaphase. We analyzed Cyclin B levels, via western blot analysis, in cells transfected
with the scrambled control siRNA or a B-Raf specific siRNA 72 hours post-transfection.
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Levels of cyclin B were not increased in the B-Raf depleted cells relative to SCR control
cells (Fig. 26, B).
Together, these data indicate that 72 hours of downregulation of B-Raf does not
lead to a spindle assembly checkpoint arrest despite the notable induction of spindle
abnormalities and the impairment of microtubule-kinetochore engagement.

Induced Spindle Assembly Checkpoint is Compromised in the Absence of B-Raf
Downregulation of B-Raf drives significant mitotic abnormalities that persist
without induction of a SAC, suggesting that B-Raf may be necessary for SAC function.
In order to determine whether B-Raf is required for activation of the SAC, scrambled
control or B-Raf downregulated cells were subjected to a classic SAC challenge with
microtubule poisons.
HFF and HeLa cells were challenged with nocodazole or taxol in order to induce
a SAC 48 hours after transfection with scrambled control or B-Raf siRNAs. After 24
hours of challenge cells were analyzed for their capacity to arrest in mitosis. Cells were
lysed and subjected to western blot analysis to evaluate Cyclin B levels as a biochemical
marker of a spindle assembly arrest. Cyclin B level are reduced to nearly undetectable
levels in cells depleted of B-Raf upon challenge nocodazole or taxol (Fig. 27) confirming
that an artificially induced SAC is not fully functional in the absence of B-Raf. Live
imaging microscopy of taxol treated cells confirmed that scrambled control cells entered
and remained in a rounded morphological state consistent with the expected induction of
metaphase arrest, whereas B-Raf depleted cells acquired a flattened morphology
following a brief rounded state induced by taxol, indicative of a breached arrest (Fig. 28).
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Figure 26 Cells do not enter mitotic
arrest in the absence of B-Raf
HFF cells were transfected with a
scrambled or B-Raf targeting siRNA. (A)
Mitotic cells were scored based on round
morphology. (B) Cells were lysed and
probed for B-Raf, the mitotic marker,
cyclin B and total ERK for a reference.
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Figure 27 Cells do not maintain a spindle
checkpoint arrest in the absence of B-Raf
HFF cells were transfected with scrambled or BRaf targeting siRNAs for 48 hours followed by a
nocodazole challenge for 24 hours. Cells were
lysed and probed for B-Raf, the mitotic marker,
cyclin B and total ERK.
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Time spent in mitosis

Time spent in mitosis

Figure 28 B-Raf depleted cells exit mitotic arrest in the presence of
taxol
HeLa cells were transfected with scrambled control or B-Raf targeting
siRNAs for 48 hours and then treated with 50nM taxol in 0.1% DMSO
for 24 hours during which time cells were imaged using live imaging
phase contrast microscopy. (A) 20 (SCR) or 17 (BE11) individual
cells were analyzed for their time spent in mitosis. (B) On average, BRaf depleted (BE11) cells spent significantly less time in mitosis
relative control cells.
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Figure 29 Cells prematurely exit metaphase
in the absence of B-Raf
HeLa cells were transfected with scrambled or
B-Raf siRNAs for 48 hours and live imaging
performed for the following 24 hours. (A)
Images were collected every 1 min over a 24 hr
period at 20X magnification. Mitosis starts at
nuclear envelope breakdown (NEB) and ends
at cytokinesis. The data was compiled from at
least 35 cells per condition from 2 independent
experiments and is graphed (B) as the average
+/- standard error.
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B-Raf Depleted Cells Exit Metaphase Prematurely
To directly test whether the SAC is compromised in B-Raf depleted cells,
scrambled control or B-Raf depleted HeLa cells were subject to live imaging phasecontrast microscopy for 24 hours. The total duration of mitosis was scored from nuclear
envelope breakdown (NEB) through cytokinesis. HeLa cells treated with B-Raf siRNA
accelerated faster through mitosis than SCR control cells, averaging 66 vs. 83 min,
respectively (Representative photo Fig. 29, A). Closer inspection revealed that B-Rafdepleted cells remained in metaphase on average 24 minutes less than non-depleted cells
(Fig. 29, B). In contrast, timing through anaphase-telophase was not significantly
affected in B-Raf siRNA-treated HeLa cells, although a modest delay in cytokinesis was
consistently observed. These results, imply that the spindle checkpoint is suppressed in
HeLa cells depleted of B-Raf.

Kinetochore Localization of Mad2 and Bub1 is Inhibited in the Absence of B-Raf
Published data in Xenopus egg extracts has indicated ERK signaling regulates the
requisite kinetochore localization of key spindle assembly checkpoint proteins. Since BRaf’s only known functions are regulated via ERK, we postulated that B-Raf regulates
localization of SAC proteins to the kinetochores. To test this possibility, kinetochore
localization of spindle checkpoint proteins Bub1 and Mad2 was analyzed in control and
B-Raf depleted cells. To do this, metaphase chromosomes were isolated from colcemidtreated HeLa cells, immunostained for the kinetochore marker, CREST, and Bub1 or
Mad2. In chromosomes isolated from scrambled siRNA transfected cells, localization of
Bub1 and Mad2 at CREST-stained kinetochores was readily detectable (Fig. 30). In
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Figure 30 Mad2 and Bub1 kinetochore localization is inhibited in the
absence of B-Raf
HeLa cells were transfected with a scrambled (SCR) or B-Raf specific
(BE11) siRNA for 72 hours prior to chromosomal isolation. Kinetochore
localization of Bub1 (B) and Mad2 (C) was analyzed using
immunofluorescence on isolated chromosomes. DNA is stained with DAPI
(blue), kinetochores are stained with CREST (red), Bub1 and Mad2 are
shown in green.

80

contrast, Bub1 and Mad2 immunostaining was greatly diminished or undetectable at the
kinetochores of HeLa cells treated with the B-Raf siRNA, demonstrating that B-Raf is
necessary for proper localization of critical spindle assembly checkpoint proteins, Bub1
and Mad2. Since kinetochore localization of spindle checkpoint proteins is an indication
of SAC activation, we conclude that B-Raf is critical for SAC activation.

Conclusions
Our lab previously demonstrated that B-Raf regulates MAPK signaling during
mitosis in Xenopus egg extracts. However, B-Raf had no known functional role in
mitosis in Xenopus egg extracts or in mammalian cells. The work described in this
chapter demonstrates that B-Raf is necessary for proper spindle assembly in Xenopus egg
extracts and in human somatic cells. Chromatin congression is severely impaired upon
B-Raf downregulation in human cells and we show evidence suggesting that
microtubules are not fully engaged with the kinetochores in the absence of B-Raf. While
such grave mitotic errors ought to elicit a spindle assembly checkpoint arrest, I have
demonstrated B-Raf depleted cells accelerate faster through mitosis and bypass the
spindle assembly checkpoint. We conclude that B-Raf contributes to several critical
mitotic functions including spindle assembly, chromatin congression, microtubule
capture and activation of spindle assembly checkpoint.
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CHAPTER 4
ONCOGENIC B-RAF DISRUPTS MITOSIS AND CAUSES CHROMOSOMAL
INSTABILITY

Introduction
Mutationally activated B-Raf is detected in ~8% of human cancers with a
particularly high frequency in melanoma (60-70%), colorectal (15-20%), papillary
thyroid (35-50%), and ovarian (30%) cancers [216, 217, 287-291]. The B-RafV600E
mutant accounts for at least 90% of all B-Raf mutations detected to date which renders BRaf into a constitutively active state [216, 224]. As such, B-RafV600E sustains 10-fold
higher levels of ERK activity in melanoma cells [292]. Ectopic B-RafV600E expression
transforms immortalized NIH 3T3 fibroblasts and mouse melanocytes in culture [216,
223, 226, 293, 294] and is required for melanoma cell proliferation, survival, and
melanoma tumor growth and vascular development in vivo [226, 295, 296]. Together,
these finding underscore crucial roles for B-Raf in tumorigenesis. How oncogenic B-Raf
is required for tumorigenesis remains poorly understood. Part of the transforming
activities of B-RafV600E may occur through subverting adhesion-dependent G1 phase
controls for cyclin D1 expression and p27 down-regulation [297, 298] and suppressing
anoikis in melanoma cells [299, 300].
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Aneuploidy is a widely recognized trait of many human cancers and is associated
with tumor progression and poor prognosis [301, 302]. Aneuploidy results from mitotic
errors in chromosome segregation due to defects in the spindle assembly checkpoint
(SAC) and centrosome amplification [242, 303]. It is widely believed that aneuploidy
itself can be a transforming event through the generation and selection of chromosomal
profiles that favor cell growth, resistance to cell death and metastatic potential. Human
melanomas are highly aneuploidy. In fact, changes in DNA copy number are detected in
greater than 95% of human primary melanomas [304, 305] suggesting that early
oncogenic events contribute to the onset of aneuploidy.
We have demonstrated that B-Raf regulates mitotic functions that are required to
ensure proper chromosomal segregation and the genomic fidelity of the cell. In this
chapter, we explore the possibility that the most common oncogenic mutation in B-Raf,
V600E, contributes to mitotic defects leading to the acquisition of aneuploidy.

Results
B-RafV600E Expression Promotes Mitotic Abnormalities in Melanoma Cells
B-Raf plays a critical role in the regulation of spindle formation, microtubulekinetochore engagement and activation of the spindle assembly checkpoint in human
somatic cells. This prompted us to ask whether the constitutively active oncogenic form
of B-Raf, carrying a V600E mutation, might have adverse effects at mitosis.

83

B-RafV600E Status in Melanoma Cells is Associated Mitotic Abnormalities
To address the possibility that B-RafV600E may have adverse effects on mitosis,
mitotic events in A375 and SK-MEL28 melanoma cells, that are known to harbor BRafV600E mutations, were analyzed by immunofluorescence microscopy. In parallel, we
examined mitoses in WM35, SbCl2, and SK-MEL5 melanoma cell lines expressing wild
type B-Raf. Normal mitotic spindles were detected in at least 90% of the mitotic figures
examined in melanoma cells with wild type B-Raf (Fig. 31). In contrast, abnormal
spindles with misaligned chromosomes were observed at a high frequency (70-85%) in
both A375 and SK-MEL28 cells (Fig. 31). These results indicate that melanoma cells
carrying B-RafV600E mutations are more prone to forming aberrant mitotic spindle
structures during cell division.

B-RafV600E Promotes Spindle Abnormalities and Centrosome Amplification in Human
Melanoma Cells
Based on the correlative findings between oncogenic B-Raf expression and
mitotic abnormalities, we hypothesized that the constitutively active B-RafV600E mutant
was responsible for causing the abnormal mitoses observed in the mutant B-Raf
melanoma cells. In experiments carried out in the Guadagno lab, by Yongping Cui, BRafV600E was introduced into SK-MEL-5 human melanoma cells with a wild type B-Raf
background. Cells were infected via a retrovirus using a pBabe-puro-B-RafV600E vector
or the corresponding empty vector control. Expression of the recombinant B-RafV600E
mutant was confirmed by western analysis (Fig. 32, A) and led to elevated phospho-ERK
levels as previously reported [306]. Strikingly, SK-MEK-5 melanoma cells transduced
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Figure 31 Aberrant chromatin congression in B-RafV600E positive
melanoma cells
Panel of human melanoma cell lines during mitosis containing wild type (WT)
or mutant (V600E) B-Raf. Microtubule spindles and DNA were detected by
staining with a α-tubulin antibody and DAPI, respectively. Magnification is
63X. (B) Graphs show the percent of normal versus abnormal spindles in
human melanoma cells at mitosis (n=200).
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Figure 32 Aberrant mitotic spindle formation and chromatin congression
in melanoma cells ectopically expressing B-RafV600E
SK-MEL5 melanoma cells were transfected with pGST, pGST-B-Raf, or pGSTB-RafV600E plasmid DNAs. (A) Western blot analysis and (B)
immunofluorescence staining of mitotic spindles and centrosomes. DNA was
detected by DAPI staining. (C) Graph of data from Sbcl2 and SK-MEL5 cells.
200 mitotic figures were analyzed for each condition per experiment. Scale bar,
5 μM.

This figure was contributed by Yongping Cui, Ph.D.
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with pBabe-B-RafV600E, but not with pBabe alone (empty vector), displayed pleiotropic
spindle abnormalities in ~76% of mitotic figures examined by fluorescence microscopy
(Fig. 32, B & C). These abnormalities include abnormal spindle morphology, multi-polar
spindles and misaligned chromosomes. Similar results were obtained in SbCl2
melanoma cells transfected with pGST-B-RafV600E constructs but not pGST empty vector
(data not shown). The abnormal spindle phenotypes were not due to over-expression of
B-Raf protein per se as ectopic expression of wild type B-Raf in SK-MEL5 cells had
little effect on spindle formation. Hence, expression of constitutively active B-RafV600E
promotes spindle abnormalities in melanoma cells.
Abnormal numbers of centrosomes often arise in tumor cells resulting in multipolar aberrant spindle structures [303]. A portion of mitotic spindles displayed multiple
poles in melanoma cells transfected with B-RafV600E (Fig. 32, B). To confirm whether
this reflects the presence of extra centrosomes, parental and B-RafV600E-modified
melanoma cells were subjected to immunostaining with an anti-γ-tubulin antibody.
Depending on the phase of the cell cycle, G1 (unduplicated) or G2 (duplicated)
centrosomes were typically detected in either parental or vector control SK-MEL-5 cells
with fewer than 5% containing greater than 2 centrosomes (Fig. 32, C). In contrast,
supernumerary centrosomes (as indicated by γ-tubulin stained foci) were detected in
~30% of interphase cells for both SbCl2 and SK-MEL5 cell lines containing the BRafV600E mutant. Co-staining of microtubules with a α-tubulin antibody revealed
multipolar spindles at mitosis in cells containing supernumerary centrosomes. This
represented about half of the abnormal spindles. The remaining abnormal spindles
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contained two centrosomes suggesting that B-RafV600E also perturbs spindle formation
independent of centrosome amplification.

B-RafV600E Drives Aneuploidy and Chromosome Instability in SbCl2 Melanoma
Cells
The results shown here demonstrate that exogenous B-RafV600E expression
promotes spindle abnormalities and centrosomal amplification in human melanoma cells.
While a large number of these cells die, some of these cells are retained in the population
despite the severity of mitotic abnormalities. It stands to reason that errors in
chromosome segregation errors may have occurred in these cells, leading to aneuploidy.
Since these experiments demonstrate that B-RafV600E drives mitotic abnormalities in cells,
which continue to divide, I decided to determine if the chromosomal composition of these
cells is changing over time. Such insights are significant since chromosomal instability
gives rise to a karyotypically varied population of cells thereby providing a pool for
selection of cells that have tumorigenic and metastatic potential.

B-RafV600E Induces Aneuploidy in SbCl2 Melanoma Cells
Most tumor cells and cell lines exhibit aneuploidy, therefore I screened several
melanoma cell lines for their chromosomal number via metaphase spread analysis.
SbCl2 cells isolated from an early primary tumor are genomically stable with a mode of
46 chromosomes (Fig. 33). In order to test whether B-RafV600E can induce aneuploidy in
this genomically stable cancer cell line, cells were retrovirally infected with a pBabe-BRafV600E vector or the corresponding empty vector control and positively expressing cells
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B.
A.

Figure 33 SbCl2 melanoma cells are near diploid
(A) Metaphase spreads were performed on SbCl2 cells and the chromosomes were stained with DAPI and
pseudocolored green for contrast. (B) 50 metaphase spreads were counted and the chromosomal
distribution s are shown. The upper panel indicated the number of chromosomes each cell contains and the
lower panel shows the percentage of cells containing 46 chromosomes or <>46 chromosomes.
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were selected for two weeks in puromycin containing media. Immunofluorescence and
western blot analysis was performed to confirm exogenous B-Raf expression and
activation of ERK (Fig. 34, A & B). Fluorescence in situ hybridization (FISH) was
performed on the cells to evaluate their ploidy. In the empty vector control cells, 5.5%
and 9.5% of interphase nuclei displayed less than or greater than two signals for
centromere probes to chromosomes 2 or 8, respectively (Fig. 35, A), which is consistent
with SbCl2 having a mode of 46 chromosomes. In contrast, B-RafV600E expressing SbCl2
cells exhibited aneuploidy at a frequency of 16.5% in chromosome 2 and 20.5% in
chromosome 8 in (Fig. 35, A). This data demonstrates a role for constitutively active BRafV600E in promoting aneuploidy in tumor cells.

B-RafV600E Drives Chromosome Instability in SbCl2 Melanoma Cells
B-RafV600E expression causes significant levels of aneuploidy in SbCl2 melanoma
cells as demonstrated via FISH analysis. It is anticipated that the persistence of spindle
abnormalities in these cells would continue to generate segregation errors and perpetually
change the chromosomal content of the cells. Therefore, SbCl2 cells were used to test
whether B-RafV600E expression can induce chromosomal instability. SbCl2 cells were
retrovirally infected and selected for expression of B-RafV600E or an empty vector control
as described above. The karyotypes of individual cells were evaluated to assess the
precise number of chromosomes per cell. To evaluate the karyotype, metaphase spreads
were prepared, chromosomes were stained with DAPI and counts were performed on 100
cells per sample. A mode of 46 chromosomes was observed in the vector control SbCl2
cells two weeks post-infection (Fig. 35, B). As expected in cell culture 50% of the
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Figure 34 Exogenous expression of B-RafV600E in SbCl2 cells
Retroviral expression of B-RafV600E or empty vector control in SbCl2 melanoma cells that endogenously express
WT B-Raf. (A) Immunofluorescence staining of DNA (blue), tubulin (red) and B-Raf (green). Threshold is
lowered until endogenous B-Raf is undetectable in empty vector control. (B)Western analysis of cell lysates
prepared from control (empty vector) or B-RafV600E overexpressing Sbcl2 cells.
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Figure 35 Aneuploidy induced by B-RafV600E in SbCl2 cells
SbCl2 melanoma cells that endogenously express WT B-Raf were retrovirally infected
to expression of B-RafV600E or empty vector control. (A) Percentage of 200 nuclei
per condition, that scored positive for aneuploidy by FISH analysis with probes to
either chromosome 2 or 8. * p-values for chromosomes 2 and 8 are <0.001 and
<0.005, respectively. Photos of FISH analysis using centromere probes specific to
chromosomes 2 (red, 2R) and 8 (green, 8G). Yellow arrows point to nuclei positive
for aneuploidy. (B and C) Percent distribution and representative examples of
chromosome numbers obtained from at least 50 metaphase spreads. Chromosomes
were detected by staining with DAPI and imaged at 100X magnification.
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control cells had some degree of aneuploidy, ranging from 29 to 48 chromosomes per
cell. In contrast, expression of B-RafV600E resulted in the complete absence of a
chromosomal mode, with aneuploidy in 94% of the cells (Fig. 35, C). B-RafV600E
expressing cells exhibited a large distribution of chromosomes ranging from 15-87
chromosomes per cell. These results demonstrate that SbCl2 cells became aneuploid due
to expression of B-RafV600E.
In order to determine if the population of B-RafV600E cells are chromosomally
unstable, cells were allowed to continue proliferating and their karyotypes were reevaluated at later time point. 52% and 48% of the control cells maintained 46
chromosomes at week four (Fig. 36, A) and week six (Fig. 36, B), respectively, and the
chromosomal variability ranged from 30 to 51 chromosomes per cell. Thus the mode and
the chromosomal variability in the control cells did not change significantly over time.
B-RafV600E cells continued to be highly aneuploid with only ~5% having 46
chromosomes. However, the chromosomal distribution was sharply reduced from 15-87
chromosomes per cell at two weeks post-infection to 18-52 at four weeks (Fig. 36, C) and
15-49 at 6 weeks (Fig. 36, D). This demonstrates that the population of B-RafV600E cells
is chromosomally unstable with an increase in the percentage of hypoploidy cells over
time.
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A.

Figure 36 Change in
chromosome number
generated by 4 and 6
weeks of B-RafV600E
expression
SbCl2 melanoma cells
endogenously expressing
WT B-Raf were
retrovirally infected to
expression of B-RafV600E
or empty vector control.
(A) Karyotype of cells
cultured for 4 weeks in the
presence of the pBabe
puro empty vector. (B)
Karyotype of cells
cultured for 6 weeks in the
presence of the pBabe
puro empty vector. (C)
Karyotype of cells
cultured for 4 weeks in the
presence of the pBabe
puro B-RafV600E vector.
(D) Karyotype of cells
cultured for 6 weeks in the
presence of the pBabe
puro B-RafV600E vector.
50 cells per condition
were analyzed.

B.

C.

D.
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B-RafV600E Induces Rapid Aneuploidy in Primary Human Cells
We have demonstrated the emergence of aneuploidy in SbCl2 melanoma cells.
While this is significant, it raises two important mechanistic questions. First, B-RafV600E
positive SbCl2 cells were selected for over a minimum of 2 weeks time. This could be
sufficient time for the cells to generate changes which could indirectly be driving
aneuploidy. Secondly, SbCl2 cells are already transformed prior to the introduction of
oncogenic B-Raf, and could therefore possess alterations that allow for the generation
and survival of aneuploid cells. Therefore it is important to test whether B-RafV600E can
induce aneuploidy rapidly in cells of a primary nature.

B-RafV600E Rapidly Induces Aneuploidy in Primary Human Melanocytes
In order to determine if B-RafV600E is capable of inducing aneuploidy in nontransformed cells, we evaluated the potential for oncogenic B-Raf to initiate aneuploidy
in primary human melanocytes (HEM cells). Melanocytes are the cell of origin in
melanoma development. This is a particularly relevant model considering that B-Raf is
mutated into its oncogenic form in nearly 70% of melanomas and is mutated 80% of
benign nevi of melanocytic origin.
To examine whether B-RafV600E expression can cause aneuploidy in HEM cells, I
transiently transfected the cells with the p-Babe-B-RafV600E vector, or the corresponding
empty vector control, using a high-efficiency, high-viability electroporation transfection
method. Transfection efficiency was monitored by visualizing GFP fluorescence of a cotransfected GFP-containing plasmid and was found to be approximately 90%. Cells were
permitted to divide for 96 hours after transfection, the equivalent two cell division cycles,
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and then subjected to FISH analysis using centromeric probes against chromosomes 3
and 10. A low background of 4.5 and 5.5% aneuploidy was observed in non-transfected
or empty vector (control) transfected cell, respectively (Fig. 37). Strikingly, 44% of
nuclei from primary human melanocytes exhibited aneuploidy in either chromosome 3 or
10 following exogenous expression of B-RafV600E (Fig. 37). Therefore, we conclude that
oncogenic B-RafV600E is sufficient to rapidly induce aneuploidy in primary human
melanocytes.

B-RafV600E Rapidly Induces Aneuploidy in hTERT Immortalized Mammary Epithelial
Cells
While B-Raf is mutated in the vast majority of melanomas, it is as well mutated
and expressed in its oncogenic form in several other tumor types including colorectal and
liver cancers, sarcomas and gliomas. In order to confirm that the induction of aneuploidy
by B-RafV600E was not specific to HEM cells, I tested the effects of B-RafV600E expression
in human mammary epithelial cells immortalized with human telomerase (hTERT
HME1s). hTERT HME1 cells were transfected and evaluated as described above for
HEM cells. As scored via FISH analysis, 7.0 and 6.5% of non-transfected or empty
vector (control) transfected cells (Fig. 38) are aneuploidy in chromosomes 3 or 10.
However, hTERT HME1 cells transfected with B-RafV600E exhibited aneuploidy in 39.5%
of the nuclei, results nearly identical to the results in HEM cells (Fig. 39). Therefore, we
conclude that oncogenic B-RafV600E is sufficient to rapidly induce aneuploidy in multiple,
non-transformed human cell lines.
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Figure 37 Aneuploidy induced by B-RafV600E in primary human melanocytes
B-RafV600E or empty vector plasmids were transfected into early passage hTERT-HME1s 96 hours post-transfection,
interphase FISH analysis was performed using probes to chromosomes 3 (red) and 10 (green), (A) representative
pictures are shown. (B) Percent aneuploidy detected in non-transfected (no TF), vector alone (Empty), and B-RafV600E.
Percent aneuploidy by FISH analysis was calculated from 200 nuclei.
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Figure 38 Aneuploidy induced by B-RafV600E in immortalized primary human epithelial cells
B-RafV600E or empty vector plasmids were transfected into early passage hTERT-HME1s 96 hours post-transfection,
interphase FISH analysis was performed using probes to chromosomes 3 (red) and 10 (green), (A) representative
pictures are shown. (B) Percent aneuploidy detected in non-transfected (no TF), vector alone (Empty), and B-RafV600E.
Percent aneuploidy by FISH analysis was calculated from 200 nuclei.
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Conclusions
B-Raf is mutated into a constitutively active oncogenic form in an extraordinarily
high percentage of melanomas and other cancers. Therefore, understanding the
mechanisms by which B-Raf elicits its oncogenic effects is of great significance. Prior to
my work the transforming activities of oncogenic B-Raf have been exclusively limited to
interphase related roles including cell cycle entry, adhesion controls and resistance to
anoikis. The results from this chapter demonstrate for the first time that expression of
oncogenic B-Raf, V600E, causes mitotic abnormalities when expressed in melanoma
cells. B-RafV600E subsequently causes melanoma cells to become aneuploid, and
destabilizes their genome. As well, expression of B-RafV600E generates rapid aneuploidy
in primary human melanocytes and primary immortalized mammary epithelial cells.
From this data, we conclude that oncogenic B-Raf, V600E, drives mitotic abnormalities,
aneuploidy and chromosomal instability.

99

CHAPTER 5
DISCUSSION
The key discoveries of this dissertation are the novel findings that B-Raf regulates
critical functions in mammalian cell mitosis, and that oncogenic B-Raf perturbs mitosis
and directly causes aneuploidy. Together, the results of my thesis research expand our
understanding of mitotic regulation and highlight the significance of B-Raf overactivation
in tumorigenesis.

B-Raf Performs Critical Functions during Mitosis
In the studies described herein, a combination of immunocytochemistry and RNA
interference was used to assess potential functions for B-Raf at mitosis in human somatic
cells. Immunofluorescence studies demonstrate that B-Raf localizes to key mitotic
structures. Consistently, functional studies demonstrate that B-Raf expression is critical
for allowing proper spindle formation, chromosome congression, microtubulekinetochore engagement and spindle checkpoint function. These are the first studies that
link B-Raf to mitotic functions in human somatic cells.

MAPK Mitotic Functions
It has long been known that MAPK signaling regulates several functions in
mammalian cell mitosis including mitotic entry [111, 117, 118] and exit [130, 131],
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spindle assembly [115] and Golgi apparatus fragmentation [135, 136, 307]. Studies in
Xenopus egg extracts have suggested that MAPK regulates the spindle assembly
checkpoint [73, 129]. However, beyond mitotic entry, a role for the MAPK cascade in
mammalian cell mitosis had not been firmly established. Work from our lab
demonstrated that B-Raf is the MEK kinase that activates the MAPK cascade during
mitosis in Xenopus egg extracts [180], however, prior to my studies it was not known
whether B-Raf had functional roles in mitosis.

B-Raf Localizes to the Cytoplasm during Interphase in Human Somatic Cells
It has long been thought that B-Raf is a cytoplasmic protein that gets transiently
recruited to the plasma membrane for Ras mediated activation upon stimulation by
mitogens. Using epifluorescence, we confirm that during interphase B-Raf exhibits
cytoplasmic localization, and nuclear exclusion, (Fig. 7). While cytoplasmic B-Raf
staining appears to be diffuse, upon close inspection, it appears that B-Raf is most highly
concentrated in the perinuclear area. Further, I have found that B-Raf distinctly
colocalizes with the early endosome during interphase (data not shown). While we did
not investigate the significance of these localization patterns, they are consistent with a
study demonstrating that endosome associated Rap1 activates prolonged MAPK
signaling through B-Raf in response to neural growth factor (NGF) [308]. It is tempting
to speculate that within endosomes B-Raf undergoes Rap1 mediated activation. Further
analyses would be required in order to make any substantial claims regarding B-Raf’s
perinuclear and endosomal localization.
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B-Raf Localizes to Mitotic Structures in Human Somatic Cells
Prior to the study presented here, B-Raf was thought to reside exclusively in the
cytoplasm. Using epifluorescence and confocal microscopy, I show that a portion of BRaf becomes associated with distinct mitotic structures in human foreskin fibroblast
(HFF) cells (Fig. 7, 8). During prophase, B-Raf undergoes a dramatic relocation to the
nuclear region, a portion of B-Raf is detected at the spindle apparatus and B-Raf is tightly
associated with the centrosomes (Figs. 7, 8, 14). B-Raf’s presence at the spindle is most
prominent during metaphase at which time it can be detected at the spindle poles, spindle
microtubules, and kinetochores. This mitotic staining pattern of B-Raf is not cell line
specific as we detected similar staining at the mitotic spindle in several other cell lines
including mouse NIH 3T3 fibroblasts (Fig. 6, 13). We propose that a portion of B-Raf is
directly associated with the microtubules during interphase, as seen by the reticular
perinuclear staining pattern (Fig. 7), and during mitosis as suggested by several
experiments in human cells and Xenopus egg extracts (Fig. 9, 10, 11). This would
account for B-Raf’s re-localization to the prophase nuclear region, where the microtubule
organizing centers reside, and its enrichment at the metaphase spindle. B-Raf is enriched
at the spindle and spindle midzone during metaphase and anaphase, respectively.
Colocalization of B-Raf to these key mitotic structures suggests that it has a role in
spindle formation and spindle dynamics during mitosis. This data indicates that a portion
of B-Raf is temporally and spatially regulated at the spindle apparatus throughout the
phases of mitosis.
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Phosphorylation of Thr599 and Ser602 is critical for Ras-mediated B-Raf
activation [160]. During interphase phospho-B-Raf (Thr599 Ser602) is largely
undetectable with the exception of weak centrosomal staining. At the onset of mitosis,
however, phospho-B-Raf (Thr599/Ser602) is prominently localized to the nuclear region
of condensing chromosomes (Fig. 15), which overlaps with the temporary localization of
active Cyclin B-Cdk1 [309]. Thus, this localization pattern is consistent with the idea
that mitotic B-Raf is activated in a Cyclin B –Cdk1 dependent manner [181]. PhosphoB-Raf (Thr599 Ser602) is readily detectable at the centrosomes throughout mitosis. This
corresponds to the localization of active forms of MEK and ERK [112, 114]. As well,
phospho-B-Raf (Thr599 Ser602) is detectable in the region of condensing chromatin
throughout mitosis and is distinctly localized to the perichromosomal space (Fig. 16, 17).
B-Raf is also phosphorylated at the midbody during telophase/cytokinesis, likewise,
active MEK and ERK localize to the midbody during telophase [112, 114]. Activated
forms of MEK and ERK have also been shown to localize to mitotic kinetochores. Upon
inspection of the isolated chromosomes, it is shown that phospho-B-Raf colocalizes
precisely at the kinetochores of metaphase cells, whereas kinetochore localization is
absent during interphase (Fig. 18). These results indicate that pools of B-Raf are active at
the spindle apparatus during mitosis. These pools colocalize with active forms of MEK
and ERK, indicating that B-Raf activates MAPK signaling at discrete mitotic sites.
Further research is necessary to determine whether different mitotic B-Raf is activated in
one location and transported to various destinations or if the pools are independently
activated.
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The kinase that phosphorylates B-Raf at the Thr599 Ser602 residues is unknown.
It would be interesting to determine whether phosphorylation of B-Raf is executed by the
same kinase throughout interphase and mitosis. Interestingly, work performed in the cellfree system of Xenopus egg extracts showed that Cyclin B-Cdk1 directly associates with
and phosphorylates Xenopus B-Raf at a Ser144 [181], a site conserved in human B-Raf.
This phosphorylation event is necessary, but not sufficient for its activation at mitosis.
Development of phospho-Ser144 specific antibodies will help to elucidate whether this
phosphorylation occurs in somatic cells and whether B-Raf phosphorylated at Ser144
associates with mitotic structures.

Our results showing that pools of active B-Raf on mitotic structures are in
agreement with a previous study detecting a small peak of B-Raf activity at mitosis of
synchronized HeLa cells [134]. Taken together, these data suggest that B-Raf may
function during mitosis in human somatic cells. Specifically, these data imply that during
mitosis B-Raf may be involved in regulating spindle assembly and spindle, chromosome
condensation, microtubule-kinetochore attachment, the spindle assembly checkpoint,
anaphase and cytokinesis. Although it was not addressed in my thesis studies, I observed
a pronounced distribution of B-Raf in the region around the mitotic spindle, which may
overlap with the localization of the fragmented Golgi and endoplasmic reticulum during
mitosis. Therefore, it is possible that B-Raf as well activates ERK signaling necessary
for mitotic fragmentation of Golgi network.
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B-Raf Regulates Mitotic Functions in Human Somatic Cells
B-Raf’s mitotic localization is strongly suggestive of a functional role during
mitosis. In my thesis studies, I tested whether B-Raf functions at mitosis in human cells
by using siRNA to selectively deplete B-Raf from cells. Knockdown of B-Raf, but not
Raf-1, had pleiotropic effects on spindle formation and chromatin congression in human
somatic cells (Fig. 22, 23).
A minimum of 80% of the mitotic figures examined from B-Raf-depleted cells
display various spindle abnormalities including unfocused spindle poles and alterations in
spindle morphology (Fig. 22). Corroborating these results is immunofluorescence
detection of B-Raf at various structures of the spindle apparatus during mitosis. A
portion of B-Raf appears to interact directly with the spindle microtubules and a pool of
B-Raf is detectable specifically at the centrioles after pre-extraction with CHAPS
detergent (Fig. 14). However, reduction of B-Raf did not appear to have an effect on
centrosome duplication or separation (unpublished observations). Instead, a high
frequency (40-50%) of aberrant spindles with unfocused poles was observed. Similarly,
Xenopus egg extracts treated with the MEK inhibitor, U0126 exhibited several
phenotypically abnormal spindle structures including monastral structures lacking
condensed chromatin [115]. Together, these findings support a possible role for the BRaf/MEK/ERK pathway in mediating spindle pole focusing. This might occur through
regulation via ERK-mediated phosphorylation of one of the various regulators implicated
in spindle pole functions including dynein, NuMA, Aurora A, and Xklp2. Alternatively,
B-Raf signaling may target structural components of the centrosome that are necessary
for the maturation or focusing of spindle poles.
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Chromosome alignment at the metaphase plate was dramatically altered in the
majority of B-Raf-depleted cells (Fig. 22). As well, NIH3T3 cells treated with the U0126
inhibitor exhibited abnormal spindles including those with unattached chromosomes
[115]. Chromosome alignment is dependent upon microtubule capture and the subsequent
countering forces that pull chromosomes poleward. Thus, the observation that
chromosomes are misaligned in the absence of B-Raf could be due to direct defects in
microtubule-kinetochore engagement. Alternatively or additionally, chromosomal
misalignment could manifest as a result from a precipitous exit from metaphase, in other
words, a defective SAC that gives insufficient time for proper chromosome congression.
In accordance with both of these options, phospho-B-Raf (Thr599/Ser602) is readily
detectable at mitotic kinetochores (Fig. 18), the site of microtubule engagement and the
SAC.

Through analysis of a marker for impaired microtubule-kinetochore engagement,
my data indicates that microtubules are not engaged with kinetochores in the absence of
B-Raf (Fig. 24) and this is confirmed through direct analysis of the microtubulekinetochore attachments (Fig. 25). CENP-E is the only protein identified to date that
directly facilitates microtubule-kinetochore engagement. Thus, it can be proposed that BRaf signaling governs CENP-E’s mitotic functions. Indeed, it is known that mitotic
phosphorylated MAPK interacts with CENP-E and that MAPK can phosphorylate CENPE on sites that regulate CENP-E’s interaction with microtubules [114].
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Another possible mechanism by which B-Raf affects chromosome congression is
that B-Raf regulates the duration of metaphase, necessary for permitting proper
chromosomal alignment. Indeed, results from imaging mitotic progression in live cells
depleted of B-Raf support this possibility. On average, B-Raf siRNA treated cells
entered anaphase 24 min earlier than control SCR-treated cells, displaying a 33%
reduction in the duration of the prometaphase/metaphase period (Fig. 29).

Despite the absence of microtubule-kinetochore attachments and chromosome
misalignment, B-Raf depleted cells continue to divide for at least 120 hours with no
indication of widespread mitotic arrest (Fig. 26). These observations suggest that the
SAC is defective in the absence of B-Raf. Bub1 and Mad2 are critical spindle checkpoint
proteins, whose kinetochore localization is a strong indicator of spindle checkpoint
activation [286]. As shown in figure 31, kinetochore localization of Bub1 and Mad2 is
blocked upon B-Raf depletion. Furthermore, B-Raf depleted cells do not maintain an
SAC when challenged with taxol (Fig. 28) and live-cell imaging showed that the
depletion of B-Raf leads to a shortening of the period from prometaphase to anaphase,
which is consistent with having a defective spindle checkpoint (Fig. 29). These results
strongly implicate B-Raf as a regulator of the SAC.
Mps1 is an essential component of the SAC network [310, 311] and functions to
localize spindle-checkpoint proteins Bub1, Mad1, and Mad2 to unattached kinetochores
[70, 73, 310]. Interestingly, it was shown that the Xenopus homologue of Mps1 is
phosphorylated by MAPK in Xenopus egg extracts at Serine-844, and this
phosphorylation is necessary for kinetochore localization of Mps1 and other spindle
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checkpoint proteins [73]. Importantly, recent data from our laboratory demonstrates that
Mps1 is indeed a target of B-Raf signaling [312]. Specifically, it was shown that B-Raf
associates with Mps1 in vivo and directs its MAPK-dependent phosphorylation and
kinetochore localization during mitosis. Therefore, we speculate that B-Raf mediated
phosphorylation of Mps1 is important for spindle checkpoint functions. While beyond
the scope of this study, it will be important to dissect the contributions of phosphorylation
events that regulate mitotic functions of Mps1. Finally, MAP kinase has been reported to
phosphorylate other critical regulators of the spindle checkpoint, Bub1 [313] and Cdc20
[129], indicating that B-Raf signaling at mitosis may target multiple components of the
spindle checkpoint network via MAPK.

We propose that B-Raf elicits its mitotic effects through MAPK signaling. This is
supported by the colocalization of B-Raf, MEK and ERK to the spindle poles and
kinetochores. However, we cannot preclude the possibility that B-Raf may have MAPK
independent mitotic functions. This could be addressed by analyzing B-Raf’s mitotic
functions in cells with compromised MEK1/2, the only identified down-stream target of
B-Raf which directly activates ERK 1/2.
B-Raf signals through MAPK to regulate gene transcription during interphase.
Therefore, it can be proposed that B-Raf indirectly affects spindle assembly and
chromosome congression rather than having a direct effect on mitosis. To address this
question, we utilized Xenopus egg extracts where B-Raf and MAPK activities are strictly
limited to mitosis. Indeed, B-Raf depletion from Xenopus egg extracts results in dramatic
effects on spindle assembly and DNA alignment (Fig. 20), suggesting that B-Raf directly
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regulates mitosis in this system. Together with the localization of B-Raf to mitotic
structures cell culture, we propose that B-Raf directly regulates mitosis in mammalian
cells.
Besides its kinase activity, B-Raf may also function as a scaffold protein. Based
on results shown here, we cannot exclude that some or all of B-Raf’s mitotic functions
are executed via scaffolding capacity. To address this concern directly, one would need
to compare WT and kinase dead B-Raf-driven mitotic phenotypes in cells depleted of
endogenous B-Raf.

In summary, our results reveal several mitotic roles for B-Raf including proper
spindle formation, chromatin congression, microtubule capture, and the spindle assembly
checkpoint. It is feasible to propose that these functions are all independent or
interdependent. In the most interdependent example, one could suggest that B-Raf is
necessary for proper functioning of the SAC, in the absence of which, microtubule
capture is mitigated, thereby inhibiting chromosome congression and perturbing the
arrangement of spindle microtubules. However, since B-Raf localizes to several key
mitotic structures including the kinetochores, centrosomes and microtubules, I would
propose that mitotic B-Raf signaling is important for regulating several mitotic functions
through independent mechanisms. For instance, B-Raf signaling may regulate the SAC
through Mps1 and microtubule-kinetochore attachment through CENP-E. A thorough
analysis of MAPK substrates at mitosis would potentially reveal other effectors of B-Raf
signaling that regulate its mitotic functions.
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Spindle assembly, chromatin congression and the SAC are all critical mitotic
elements necessary for proper chromosome segregation. While I did not perform
karyotype analysis on B-Raf depleted cells, it is likely that these cells become aneuploid
and chromosomally unstable. The demonstration that B-Raf regulates critical mitotic
functions opens a new avenue in addressing how oncogenic B-Raf contributes to
tumorigenesis.

Oncogenic B-Raf Deregulates Mitosis Causing Aneuploidy and Chromosomal
Instability
Aneuploidy is a hallmark of cancer and it is associated with tumor progression
and poor clinical prognosis [301, 302] and has a causal role in tumorigenesis [263, 277,
314]. As described previously, B-Raf is overactivated in the majority of human
melanomas [216]. My studies presented in this section, demonstrate that the main
activating B-Raf mutation deregulates mitosis and provokes aneuploidy.

Cellular Effects of Oncogenic B-Raf
The vast majority of oncogenic B-Raf mutations cause constitutive activation of
the MAPK cascade. Prior to and during my thesis studies, a variety of experiments have
revealed several cellular roles through which B-RafV600E may elicit its oncogenic effects
including cell survival, anchorage independent cell cycle progression, and invasion.
However, the question of how B-Raf contributes to tumorigenesis is not fully understood.
Soon after the 2002 discovery that B-Raf is mutated in a wide variety of tumors, it
was demonstrated that oncogenic B-Raf, specifically B-RafV600E, is necessary for cell
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survival in B-RafV600E expressing cells. siRNA and shRNA-mediated downregulation of
B-RafV600E causes inhibition of ERK signaling and induces cell cycle arrest and apoptosis
in cultured cancer cells [225, 226, 315].
Normal cells require adhesion for signaling and survival [316]. Loss of adhesion
causes normal cells to undergo anoikis, whereas tumor cells develop the capacity to resist
anoikis [317]. B-RafV600E expression is necessary for anoikis resistance in melanoma
cells [299] and this is dependent on B-RafV600E’s negative regulation of pro-apoptotic
proteins Bad and Bim [300].
In addition to anoikis, normal cells die when they are subjected to a low-oxygen
environment. In contrast, the central tumor zone is hypoxic and tumor cells must evolve
mechanisms for survival under such conditions [318]. It has been shown that B-RafV600E
induces expression of hypoxia inducible factor-1α (HIF-1α) and its expression is essential
for melanoma cell survival in a hypoxic tumor-like environment [319]. Together, these
data demonstrate that B-RafV600E mediates survival in melanoma cells.
In addition to cell survival, B-RafV600E appears to regulate cell cycle progression
in an anchorage independent manner. In normal human melanocytes, anchorage to an
extracellular matrix is necessary for growth factor activation of ERK1/2, which leads to
induction of cyclin D1 and downregulation of p27Kip1, both key events in G1 to S phase
progression [298, 320]. B-RafV600E expression in melanoma cells causes constitutive
expression of cyclin D1 and down regulation of p27Kip1, in the absence of cellular
adhesion and growth factors [297]. Growth arrest concurrent with a decrease in
expression of cyclins D1 and D3 was observed following downregulation of B-RafV600E
in human melanoma cells [226, 298]. Brn-2, a transcription factor involved in the
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proliferation of melanoma cells [321], was also downregulated following siRNA
mediated reduction of B-RafV600E [322].
Besides its role in progression from G1 to S phase, recent evidence suggests that
B-RafV600E regulates the G2 to M phase progression. Required for melanoma growth is
Skp2 [297], an E3 ubiquitin ligase that targets multiple proteins for degradation, thus
promoting the G2-M phase transition [323-328]. In melanoma cells B-RafV600E induces
expression of Skp2, suggesting that B-RafV600E mediates entry into mitosis [329].
A hallmark feature of tumor cells is the acquired ability to invade nearby tissues
[330]. It has been shown that B-RafV600E upregulates expression of several matrix
metalloproteinases (MMPs) [331, 332], which are known to mediate invasion through
cleavage of extracellular matrix components [333]. Using a matrigel assay, it was shown
that downregulation of B-RafV600E decreases the invasive potential of PTCs.
Additionally, it has been demonstrated that the actin cytoskeleton and focal adhesion in
melanoma cells is disrupted by B-RafV600E expression through MAPK activation of Rnd3
[334]. Such results implicate B-RafV600E in the promotion of tumor invasion.
These studies demonstrate several mechanisms through which B-RafV600E drives
cell cycle progression and survival under tumorigenic conditions. However, B-RafV600E
expression and its downstream effectors are not sufficient for transformation to occur. It
is widely speculated that loss of tumor suppressors, such as p16INK4a, must accompany BRafV600E for tumorigenesis to occur. My thesis studies demonstrate that B-RafV600E
causes widespread genomic changes through disregulation of mitosis. Such a mechanism
could provide the heterogeneity through which other necessary genomic changes could
arise.
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B-RafV600E Expression Drives Mitotic Abnormalities
B-RafV600E can transform immortalized melanocytes and mouse fibroblasts in
vitro [216, 223, 225] but how it exerts its oncogenic effects has been an important area of
study. Our studies investigated the mitotic effects of oncogenic B-RafV600E in cultured
human melanoma cells. Data from these studies show for the first time that B-RafV600E
induces pleiotropic spindle abnormalities, chromosome misalignment and supernumerary
centrosomes (Fig. 32). A high incidence of spindle abnormalities, similar to those
observed from ectopic expression of the B-RafV600E mutant, were also found in melanoma
cells carrying endogenous B-RafV600E mutations but not in wild type B-Raf melanoma
cells (Fig. 31) [335]. Thus, we conclude that oncogenic B-RafV600E abrogates mitosis in
human melanoma cells.
The spindle abnormalities induced by B-RafV600E include a high percent of
multipolar spindles due to cells having 3 or more centrosomes. As well, B-RafV600E
causes abnormalities in spindle assembly and chromosome alignment independent of
centrosomal amplification in approximately 50% of abnormal mitoses. The mechanisms
that generate these abnormalities have yet to be defined. One possibility is that BRafV600E deregulates the proteins involved in microtubule capture, thereby leading to the
observed abnormalities. Analyzing the mitotic localization and substrates of B-RafV600E
would shed light on these mechanisms. Like B-RafV600E, expression of oncogenic Ha-ras
induces mitotic abnormalities in mouse NIH3T3 cells, including multipolar spindles and
misaligned chromosomes, and it has been proposed that oncogenic Ras deregulates
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spindle assembly [131]. It is exceedingly rare for Ras and B-Raf mutations to coincide in
human tumors, therefore suggesting that they elicit overlapping effects.
In the absence of B-Raf the SAC is not full activated, thus causing early mitotic
exit and most likely errors in the chromosome segregation. Consistent with this, recent
studies from the Guadagno laboratory demonstrated that B-RafV600E signaling promotes
hyper-activation of the spindle checkpoint causing a delay in mitotic progression [306].
This is mediated, at least in part, through Mps1, a known target of MAPK signaling.
Depleting cells of Mps1 by siRNA alleviates the checkpoint effects induced by BRafV600E [306]. It is also possible that, due to B-Raf’s uncontrollable high activity, it
targets unusual substrates, yet to be identified. Interestingly, published evidence
indicates that both an under-activated and over-activated SAC compromises the timing
and quality of chromosome segregation during anaphase leading to generation of
aneuploid cells [263, 276, 277, 314]. We propose that by over-activating the SAC,
oncogenic B-RafV600E induces aneuploidy. In contrast to our studies, oncogenic Ras has
been shown to shorten a nocodazole-induced SAC in rat thyroid cells, and it does this in a
MAPK independent manner [231]. These data suggest that oncogenic Ras may regulate
the SAC through different mechanisms than B-RafV600E.

B-RafV600E Expression Causes Chromosomal Instability
It is well understood that mitotic errors drive aneuploidy. Therefore, it was not
surprising that aneuploidy resulted from the mitotic abnormalities generated by
introducing the B-RafV600E mutant into SbCl2 melanoma cells (data not shown) and SKMEL5 melanoma cells (Figure 32). Many of the B-RafV600E-expressing cells died,
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probably due to losses of vital chromosomes. However, experiments in SbCl2 cells
showed that many cells continued to survive and proliferate for 4-6 weeks of extended
culturing. These cells continued to exhibit abnormal chromosomes numbers that changed
over time and failed to establish a stable karyotype, as evident by the absence of a
chromosomal mode (Fig. 35, 36). Indeed this data is supported by previously published
findings that induced B-RafV600E expression in rat thyroid cells increases micronuclei
formation 2-fold, indicating that chromosomes or chromosome fragments are lost during
mitosis [336]. Interestingly, the vast majority of B-RafV600E-expressing SbCl2 cells were
hypoploid, the significance of which remains to be addressed. Hypoploidy is thought to
arise from loss of chromosomes to micronuclei [337], a result of mitotic abnormalities
that generate lagging chromosomes. Oncogenic Ras expression causes lagging
chromosomes and micronuclei formation in NIH3T3 cells harboring mutant p53 [338]
and in rat thyroid cells [339], in a MAPK dependent manner. This suggests that BRafV600E and oncogenic Ras generate mitotic abnormalities that lead to aneuploidy.
However, a role for Ras in mitosis has not been confirmed in human cells.
The mechanisms by which B-RafV600E drives chromosomal instability have yet to
be elucidated. One possibility involves Mps1, a spindle checkpoint kinase identified as a
potential target downstream of the B-Raf/MEK/ERK signaling pathway [73, 306, 312].
Mps1 levels are elevated by constitutive B-RafV600E signaling in melanoma cells, which
allows for hyper-activation of the spindle checkpoint [306]. A hyper-activated spindle
checkpoint could, in turn, contribute to chromosome segregation errors that lead to
aneuploidy. Consistent with this proposal, elevated levels of Mad2 expression are
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observed in various tumors defective in the Rb pathway [340] and are sufficient to induce
chromosome instability, aneuploidy, and tumorigenesis in mice [277].
It was shown that immortalization itself can indirectly cause aneuploidy [270]. It
was therefore proposed that aneuploidy-causing agents must induce aneuploidy in preimmortalized cells in order to fully meet the criteria as an aneuploidogen [232]. My
results have shown that B-RafV600E induced aneuploidy in hTERT-immortalized epithelial
cells (Fig. 38), thereby confirming B-RafV600E as a direct mediator of CIN. The results
described here further show that oncogenic B-RafV600E is sufficient to rapidly induce
aneuploidy in primary human melanocytes (Fig. 37). Together, these results indicate that
B-RafV600E-induced CIN could be a mechanism for induction of aneuploidy in both
melanomas and other human cancers carry activating B-Raf mutations.
A large proportion (~82%) of benign nevi harbor activating B-Raf mutations
[220] lending to the idea that B-Raf activation is an early and critical step in the
development of melanocytic neoplasia. While genetic evidence supports an early role for
B-RafV600E in nevi formation [227], sustained B-RafV600E activity is also associated with
oncogene-induced senescence [341, 342], explaining why most nevi never develop into
invasive melanomas and remain dormant over long periods of time. We speculate that
induction of aneuploidy in proliferating melanocytes creates additional genetic changes,
which, if tolerated, contribute to melanoma initiation. This would be in line with several
reports showing that additional mutations in melanoma susceptibility genes (i.e. p16INK4a,
ARF, PTEN) are needed to cooperate with oncogenic B-Raf (or Ras) to allow for
melanoma initiation [341].
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Several studies would further help confirm a role for B-RafV600E induced
aneuploidy in tumorigenesis. First, karyotypic evaluation of benign nevi harboring the BRafV600E mutation would reveal whether the oncogene induces aneuploidy early in
tumorigenesis. Since my studies in primary melanocytes and immortalized primary
epithelial cells demonstrated that B-RafV600E induces rampant aneuploidy after only 2 cell
divisions, I would predict that some benign nevi are aneuploid. However, this study
would have to be conservatively analyzed, since only a minority of benign nevi ever
proceed to melanomas. It is perhaps feasible that B-RafV600E induces senescence in the
majority of nevi, prior to the selection of a large number of aneuploid cells.
It would also be of interest to determine whether the initial aneuploidy induced by
B-RafV600E, in human primary melanocytes or immortalized epithelial cells, is sufficient
for transformation. These experiments could be conducted utilizing an inducible BRafV600E vector, such as an estrogen receptor B-RafV600E-fusion. Once B-RafV600E
induces aneuploidy in cells, expression of B-RafV600E could be turned off and surviving
cells would be selected and grown in soft agar. It would be predicted that the majority of
cells would depend to B-RafV600E expression for survival. However, a minority of cells
could acquire the proper combination of aneuploidy to become capable of survival and
colony formation. Mathematical modeling, such as is available through Moffitt Cancer
Center’s Integrated Mathematical Oncology group, would be a useful tool in determining
how well these experiments reflect a clinical model for melanoma progression.

Aneuploidy induced by mitotic errors leads to CIN in nearly all cases reported
[232]. The effects of CIN cannot be understated as it gives rise to a continuously
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changing gene expression pattern. Frequent changes in the genomic profile of cells
within a population allow for rapid Darwinian adaptation to the intra- and extracellular
environment. Thus, selection of the appropriate combinations of CIN can not only drive
tumorigenesis, but may provide a mechanism for generating cells capable of invasion,
metastasis and drug resistance.

Relevance for Therapeutics
The most common treatment modality for melanomas is tumor resection alone or
in combination with immunotherapy, chemotherapy or radiation for advanced stage
disease. Therapies targeted against B-Raf or B-RafV600E, its oncogenic form, have
recently been tested in clinical trials, however, most have not shown strong efficacy as
single agents [343]. Rational efforts have turned toward combination therapies, targeting
multiple signal transduction pathways or combining B-Raf inhibitors with
chemotherapeutic agents. In fact, unpublished data from our lab (not reviewed in this
thesis) demonstrates that sequential use of placitaxol and a B-RafV600E inhibitor synergize
to induce caspase-dependent cell death. Another rational therapeutic strategy employs
the use of geldanamycin derivatives, since it has been shown that B-RafV600E stability is
Hsp90 dependent, while WT B-Raf stability is independent of Hsp90 [344]. As with
other efforts, this appears to be most beneficial in combination with other agents [345].
It is interesting to speculate on how our findings might contribute to the
development of cancer therapeutics for use against B-RafV600E positive tumors. Classic
chemotherapeutic agents and some modern rationally developed drugs target mitosis as
an effective means of killing cancer cells. In elegant and elaborate live-imaging studies,
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it was recently shown that these agents induce mitotic cell death via caspase-dependent
mechanisms, which are dependent upon a prolonged, cyclin B-induced mitotic arrest
[346]. Therefore, I would propose that development of agents that stabilize cyclin B
combined with a caspase activator would synergize with existing drugs in many tumor
types, including B-RafV600E-positive tumors. My work and the work of others from the
Guadagno lab [306, 312] have demonstrated that B-Raf regulates the SAC and that BRafV600E generates an extended SAC. While we have not directly demonstrated that BRafV600E stabilizes cyclin B, such stability could enhance the efficacy of
chemotherapeutic agents, thus arguing against the use of B-RafV600E inhibitors.
Aneuploidy is another interesting feature of tumor cells that may be useful to
consider in the treatment of cancers. Aneuploidy exists in nearly all solid tumors and is
directly driven in primary cells through B-RafV600E, an early mutation in many tumors. It
is reasonable to speculate that aneuploidy-driven intratumoral heterogeneity would
frequently lead to drug resistance even with the most appropriately targeted therapies. It
has recently been proposed that aneuploidy not only drives tumorigenesis, but can be
protective [263] when aneuploidy drives specific combinations of gene expression.
While 96 hours of B-RafV600E expression generates viable aneuploid cells, the majority of
cells are not viable after prolonged expression of B-RafV600E, thus supporting the idea that
some or most aneuploidy is not tolerated long-term. Therefore, it may be feasible to
utilize known aneuploidogens to induce a wide-spread intolerable aneuploidy load in an
effort to kill tumor cells.
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Summary
Mitosis is a complex and critical stage of the cell cycle. While mitosis has been
studied for well over a century, the players and the consequences are still being
elucidated and debated. Likewise, the cancer biology field has generated volumes of
data; however, we still have much to learn about tumorigenesis. B-Raf has been
identified as an oncogene in a strikingly high number of tumors and it has therefore
become fundamental to understand how it contributes to cancer. Through the work in
this thesis, I have demonstrated that B-Raf is necessary for regulating mitosis, the cell
cycle stage that maintains the cell’s genomic integrity. Genomic changes provide cells
with the capacity to acquire new features and new functions. It is quite feasible that
advantageous changes are selected to promote tumor initiation, progression, metastasis
and drug resistance. Therefore, our findings that oncogenic B-Raf disregulates mitosis
and drives genomic instability open a new path for understanding how B-Raf contributes
to tumorigenesis (Fig. 39).
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Figure. 39 Model for B-Raf mediated mitosis
B-Raf regulates critical mitotic functions which lead to proper chromosomal
segregation thus maintaining the diploid nature of the daughter cells.
Contitutively active B-RafV600E disregulates mitosis thereby causing
missegregation of chromosomes and producing aneuploid daughter cells. a. BRaf regulates the MAPK pathway; B-RafV600E overactives the MAPK pathway;
b. B-Raf signaling regulates spindle assembly and kinetochore functions
including microtubule-kinetochore engagement and the spindle assembly
checkpoint; B-RafV600E disregulates these functions; c. Proper mitosis leads to
proper anaphase onset and accurate chromosome segregation; disregulated
mitosis causes premature anaphase onset and lost and missegregated
chromosomes; d. Proper chromosomes segregation generates diploid daughter
cells whereas missesgregation caused by B-RafV600E renders the daughter cells
aneuploid.
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CHAPTER 6
MATERIALS AND METHODS

Cell Culture and Cell Synchronization
Human foreskin fibroblasts (HFF), HeLa and NIH3T3 cells were cultured in
DMEM (Gibco) containing 10% newborn calf serum (Gibco) and 46µg/ml gentamycin.
Cells were synchronized at G2/M with 50nM taxol in 0.1% DMSO for 30 hours and
treated with 30µM U0126 or 0.1% DMSO for 6 hours prior to cell collection. SK-MEL5,
SK-MEL28, and A375 human melanoma cell lines were obtained from American Type
Culture Collection (ATCC, Manassas, VA) and maintained in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum (FBS). SK-MEL5 cells are
wild type for B-Raf, while SK-MEL28 and A375 cells carry B-RafV600E mutations [216,
292]. Sbcl2 and WM35 melanoma cells, originally derived from early radial growth
phase primary melanomas, were obtained previously from M. Herlyn (Wistar Institute,
Philadelphia, PA). Sbcl2 and WM35 cells are wild type for B-Raf and were grown in 2%
tumor media (4:1 mix of MCDB153/L15 media, 2% FBS, 5 μg/ml insulin, 1 mM CaCl2).
To further confirm the absence of an activating mutation in B-Raf, phospho-ERK levels
were assessed for SK-MEL5, Sbcl2, and WM35 melanoma cells switched to 0.5% FBS
for 24 hr. All three melanoma cell lines exhibited minimal ERK activity whereas SKMEL28 and A375 (both containing B-RafV600E mutations) cells showed robust levels of
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phospho-ERK (data not shown). Human Mammary Epithelial cells immortalized with
human telomerase (hTertHME1 cells), were gifted to us by Huntington Potter at the
Johnnie B. Byrd Alzheimer’s Center and Research Institute at the University of South
Florida (Tampa, FL). Cells were cultured in MEGM media from Lonza. Primary Human
Epidermal Melanocytes (HEM) were purchased from ScienCell Research Laboratories
and cultured in Melanocyte Medium from ScienCell. Primary cells were transfected
using the Nucleofector system from Amaxa, now part of Lonza, using kits V and NHEM
for hTertHME1 and HEM, respectively. Cells were co-transfected with GFP for
assessment of transfection efficiency.

Transfections and Retroviral infections
Cells were grown to approximately 70% density in 12-well plates and transfected
with 21-mer double stranded oligo short interfering RNAs (siRNAs) to human B-Raf
specific sequences at exon 11 (BE11) [AAAGAATTGGATCTGGATCAT] or exon 3
(BE3) [AAGCTAGATGCACTCCAACAA] or, to C-Raf specific sequence
[AATAGTTCAGCAGTTTGGCTA] obtained from Qiagen. A scrambled siRNA for BRaf or C-Raf sequences was used in parallel as a control. siRNAs were used at 110 nM.
488λ-conjugated scrambled oligo was used to verify transfection efficiency. By 48-72
hours, protein levels for B-Raf or C-Raf decreased 85-95% as confirmed by Western
blotting.
pBabe-puro and pBabe-puro-B-RafV600E retroviral vectors were a generous gift
from Dr. Daniel Peeper (The Netherlands Cancer Institute). Retroviral vectors were
transfected into HEK 293T replication-defective packaging cells for retrovirus
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production. Melanoma cells were infected with pBabe-puro or pBabe-B-RafV600E
retroviruses as described and selected in puromycin (0.8 μg/ml) for up to 10 days.
Puromycin-resistant colonies were pooled and checked for ectopic B-RafV600E expression
by immunoblot analysis.
Human melanocytes or hTERT-HME cells were transfected using the
Nucleofector system from Amaxa. Transfection efficiencies were monitored by
evaluating green fluorescent cells following co-transfection with pMaxGFP vector from
Amaxa.

Immunoblot Analysis
Cells grown in 12-well or 6-well dishes were washed with PBS and scrape-lysed
in ice-cold TNES buffer containing protease and phosphatase inhibitors (50mM Tris·Cl
pH 7.4, 1% NP40, 2mM EDTA, 100mM NaCl, 20µg/ml aprotenin, 20µg/ml leupeptin,
500µM PMSF, 40mM β-glycerophosphate, 500µM Na3VO4, 20mM NaF), incubated on
ice for 30 minutes and centrifuged for 30 minutes at 14Xg at 4º. Supernatants were
analyzed for protein concentrations were determined by a BCA protein assay (Pierce) and
analyzed by a spectrophotometer (BioRad). Cell lysates were separated by SDS-PAGE,
and electrotransferred onto PVDF, 0.45µm membranes. Membranes were blocked in 5%
milk/0.15% Tween 20 for 1h at room temperature, incubated with primary antibodies
against B-Raf and α-tubulin (detailed above), total ERK, C-Raf (BD Transduction labs),
CAS (BD Transduction Labs), Cyclin B (Santa Cruz) and Beta-actin (Abcam) diluted in
5% milk/0.15% Tween 20 for 1h at room temperature and washed 3X in 0.15% Tween
20/PBS. Membranes were incubated for 1h at room temperature with goat anti-mouse
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(Jackson ImmunoResearch Laboratories) or goat anti-rabbit (Sigma) alkaline
phosphatase-conjugated secondary antibodies diluted in 5% milk/0.15% Tween 20,
washed 4X in 0.15% Tween 20/PBS, incubated for 5 minutes in alkaline phosphatase
buffer pH 9.5, 5 minutes in CDP-Star chemiluminescence substrate (Roche Diagnostic)
and exposed to blue sensitive autoradiography X-Ray film (Molecular Technologies).
Band densitometry data was performed using Image Quant analysis.

Microtubule Depolymerization by Cold Treatment
For cold-induced microtubule depolymerization, cells transfected with B-Raf or
control (scrambled) siRNA were grown on coverslips in 35 mm dishes. Media was
removed, replaced with ice-cold media, and dishes were subsequently incubated on ice
for 10 minutes to induce depolymerization of unattached kinetochore-microtubules.
Cells were then fixed in 4% paraformaldehyde and processed for immunocytochemistry
as described above.

Nocodazole-Induced Microtubule Depolymerization
HFF and HeLa cells were grown overnight on coverslips. Nocodazole was added
at 125ng/mL (HFF) or 25ng/mL (HeLa) for 2 hours at 37º to depolymerize microtubules.
Immunofluorescence was performed as described above.
CSF extracts were generated from unfertilized Xenopus oocytes as described
below and activated into S-phase using 0.4mM CaCl2 and cycled into a stable mitotic
state with addition of equal volume of CSF extract. Reactions were incubated in the
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presence of 200/µl sperm DNA for 75 minutes at 24ºC to allow for spindle formation
alone, with DMSO or with 10ng/µl nocodazole. Microtubules were fixed and spun down
as previously described [115]. The pellet was resuspended in SDS sample buffer,
separated by 10% SDSPAGE, and immunoblotted for α-tubulin and B-Raf.

Immunocytochemistry
Cells grown on glass coverslips were fixed at 4º in 4% paraformaldehyde,
permeabilized with 0.5% triton-X-100 and blocked in 2% BSA. Alternatively,
cytoplasmic proteins were solubilized using 1% CHAPS in PHEM buffer containing
protease and phosphatase inhibitors (60mM Pipes, 25mM Hepes pH 6.9, 10mM EGTA,
4mM MgSO4, 1µg/ml aprotenin, 1µg/ml leupeptin, 1µM pepstatin, 50mM βglycerophosphate, 200µM Na3VO4) for 60 seconds at room temperature, fixed at 4º in
4% paraformaldehyde and blocked in 2% BSA. Cells were incubated in 2% BSA for one
hour with primary antibodies against B-Raf (Santa Cruz or Upstate), α-tubulin (Sigma) or
Centrin (kindly provided by Jeffrey Salisbury at Mayo Clinic), washed 3X in PBS,
incubated in 2% BSA for one hour with 488 or 594 Alexa Fluor secondary antibodies
(Molecular Probes) and washed 3X in PBS. Cells were mounted with Prolong Gold
containing DAPI (Molecular Probes).
To visualize B-Raf at the centrioles, cytoplasmic proteins were pre-extracted
using 1% CHAPS in PHEM buffer containing protease and phosphatase inhibitors (60
mM Pipes, 25 mM Hepes pH 6.9, 10 mM EGTA, 4 mM MgSO4, 1 µg/ml aprotenin, 1
µg/ml leupeptin, 1 µM pepstatin, 50 mM β-glycerophosphate, 200 µM Na3VO4) for 60
seconds at room temperature, fixed at 4º C in 4% paraformaldehyde and blocked in 2%
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BSA. Pre-extracted cells were then incubated with a C-terminal peptide B-Raf
polyclonal antibody (sc-166) obtained from Santa Cruz Biotechnology (Santa Cruz) and
co-stained with a mouse monoclonal centrin antibody kindly provided by Jeffrey
Salisbury (Mayo Clinic, Rochester) to visualize centrioles.

Chromosome Isolations
Cells were treated with 1µg/mL colcemid for 2 hours, harvested by trypsinization
and washed with PBS. Cells were swollen in 75mM KCL for 10 minutes at 37º and
subsequently spun onto polylysine coated coverslips at 1800rpm for 8 minutes. Cells
were immersed in KCM buffer containing 120mM KCl, 20mM NaCl, 10mM Tris-HCl
ph7.5, 0.5mM EDTA and 0.1% Triton-X for 10 minutes at room temperature.
Immunostaining was carried out at room temperature. Cells were exposed to primary
antibodies against phospho-B-Raf (Santa Cruz) and CREST (Antibodies Incorporated)
diluted in 2% BSA in KCM for one hour, washed twice with KCM followed by 488 or
594 Alexa Fluor secondary antibodies (Molecular Probes) and washed 2X with at room
temperature. Immunostaining was performed as described above except BSA and
antibodies were diluted KCM buffer and cells were washed in KCM buffer followed by
one final wash with PBS prior to mounting coverslips as described above.

Fluorescence in situ Hybridization (FISH) Analysis and Metaphase Spreads
Cells were treated with 1µg/mL colchicine for 2 hours, harvested by
trypsinization and washed with PBS. Cells were swollen in 65mM KCL for 5 minutes at
37º, fixed in cold acetic acid/methanol for 5 minutes at 4º, dropped onto slides and dried
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at room temperature. For metaphase spreads, cells were then stained with DAPI and
viewed with a Nikon E800 fluorescence microscope with a 60x/1.40NA plan apo oil
immersion objective. Images were captured with a Roper Coolsnap HQ CCD camera and
processed with Metamorph 5.0 and Adobe Photoshop 6.0 software. FISH analysis on
hTertHME1 and HEM cells were carried out 96 hours post-transfection. For FISH
analysis, slides were stained with Cytocell enumeration probes against chromosomes 2 or
3, and 8 or 10, conjugated with FITC or Cy3.5, respectively (Rainbow Scientific).
Staining was carried out according to the manufacturer’s protocol. FISH samples were
viewed with a fully automated, upright Zeiss Axio- ImagerZ.1 microscope with a 20X
objective, and DAPI, FITC and Rhodamine filter cubes. Images were produced using the
AxioCam MRm CCD camera and Axiovision version 4.5 software suite. P-values were
calculated using a 2-sample test for equality of proportions with continuity correction.

Microscopy
Fluorescent images of mitotic figures were viewed with a Nikon E800
fluorescence microscope with a 60X/1.40NA plan Apo or 100X/1.3NA plan Fluor oil
immersion objective. Images were captured with a Roper Coolsnap HQ CCD camera
controlled with Metamorph software 5.0, saved as Tif. files, and transferred into Adobe
Photoshop 8.0 software for final processing. Phospho-B-Raf images were viewed on a
fully automated, upright Zeiss Axio-Imager Z.1 microscope with a 63X/1.40NA oil
immersion objective and images were produced using the AxioCam MRm CCD camera
and Axiovision version 4.5 software suite. Confocal images were captured through a
63X/1.40NA oil immersion objective using a DMI6000 inverted Leica TCS SP5 tandem
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scanning microscope. Images and Z-stacks were produced with three cooled
photomultiplier detectors and the LAS AF version 1.5.1.889 software suite. Phase
contrast images of nocodazole-treated HeLa cells were acquired on a Nikon TE 2000-s
microscope using a 20X objective lens.
Time-lapse live imaging of HeLa cells was performed with an inverted Nikon
TE2000-S using a 20X 0.4NA Ph1 phase lens (Nikon). An FCS2 closed chamber system
(Bioptechs, Inc., Butler, PA, USA) was used to infuse media and CO2 at a rate of 5 mL
per hour. Phase-contrast images were captured once per minute using a Retiga 1300
(QImaging Corporation, Canada) camera and IPLab 3.61 (BD Biosciences) software.
Images were saved individually as Tif. files and incorporated into Image Pro Plus 6.2
(Media Cybernetics, Inc) to generate sequence file time lapse movies. The mass
projections were 16 images taken through the Z dimension every 0.4um. Images were
projected over one another in Maximum Projection to illustrate depth of field through the
cell. The signal was enhanced using opacity (transparency) to demonstrate colocalization
between B-Raf and microtubules.
The CENP-E, CREST mass projection was rendered 360 degrees around the yaxis to display colocalization in all 3 dimensions (x, y, z). For CENP-E, CREST
colocalization, Samples were viewed with a Leica DMI6000 inverted microscope, TCS
SP5 confocal scanner, and a 63X/1.40NA Plan Apochromat oil immersion objective
(Leica Microsystems). 405 Diode, 488 Argon, and 594 HeNe laser lines were applied to
excite the samples and tunable filters were used to minimize crosstalk between
fluorochromes. Image sections at 0.5 µm were captured with photomultiplier detectors
and prepared with the LAS AF software version 1.6.0 build 1016 (Leica Microsystems).
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Images of colocalized pixels were prepared with LAS AF software and analyzed for
CENPE intensity using Image Pro Plus 4.5 (Media Cybernetics, Maryland).
The Imaris deconvolution images were created by processing z stack images
generated by the confocal microscope through AutoDeblur deconvolution software
(Mediacybernetics Inc.) using default settings. The resulting z-stack images were then
imported into Imaris version 5.5 (Bitplane Inc.). 3D isosurface renderings were created
by adjusting the intensity thresholds for each color channel.

Spindle Assembly in Xenopus Egg Extracts
Cytostatic factor (CSF) arrested extracts were prepared from unfertilized Xenopus
eggs and spindle assembly reactions were preformed as described [347], except that
extracts were cycled into mitosis using recombinant nondegradable cyclin B (75 nM
final). Rhodamine-labeled bovine brain tubulin (Cytoskeleton) was added to a final
concentration of 0.15 µg/µl in extracts to visualize microtubules. B-Raf (Santa Cruz) or
IgG control (Sigma) antibodies were used for immunodepletions from CSF extracts prior
to their activation and cycling. To monitor spindles and associated chromosomes, 2 µl of
extract and 1 µl of Hoechst/fixative (25% glycerol, 7.4% formaldehyde, 0.1 mM Hepes
pH 7.5, 4 µg/ml bisbenzimide) were applied to a microscope slide and examined by
immunofluorescence.
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